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ABSTRACT 
 
Spinal cord injury (SCI) leads to increased anxiety and depression in as many as 
60% of patients. Yet despite extensive clinical research focused on understanding the 
variables influencing psychological well-being following SCI, risk factors that decrease 
psychological well-being remain unclear. We hypothesized that excitation of the 
immune system, inherent to SCI, may contribute to the decrease in well-being.   
We used a battery of established behavioral tests to assess depression and anxiety 
in contused rats and (1) characterized psychological well-being as a function of SCI 
severity, (2) examined peripheral (serum) and central (hippocampi and spinal cord) 
inflammation in relation to psychological well-being post SCI, and (3) explored whether 
social enrichment, as a modulator of psychological well-being, could improve overall 
recovery post SCI, by housing contused animals either alone, or with an injured or an 
intact cagemate. 
Following SCI, the contused subjects showed one of three profiles: depression-
like, depression- and anxiety-like, or no signs of decreased psychological well-being. 
Subjects exhibiting a purely depression-like profile showed higher levels of pro-
inflammatory cytokines peripherally, whereas subjects exhibiting a depression- and 
anxiety-like profile showed higher levels of pro-inflammatory cytokines centrally 
(hippocampi and spinal cord).  These changes in inflammation were not associated with 
injury severity; suggesting that the association between inflammation and the expression 
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of behaviors characteristic of decreased psychological well-being was not confounded 
by differential impairments in motor ability.  
Social enrichment, in the form of group housing, did not improve psychological 
well-being post SCI. Depression- and anxiety-like signs were found in all group housing 
conditions. Unexpectedly, we found that the intact animals housed with contused 
subjects showed depression- and anxiety-like signs similar to those of contused subjects, 
indicating that their psychological well-being was affected by the presence of an injured 
cagemate.  This is reminiscent of the caregiver effect in humans, specifically the 
manifestation of symptoms of depression in individuals who care for patients suffering 
with a chronic illness, such as SCI. 
These experiments demonstrate that the depression and anxiety patients 
experience following spinal cord injury is not due solely to psychosocial factors, but 
may also, in part, result from increased immune activation following the injury.  
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CHAPTER I  
INTRODUCTION 
 
The incidence of spinal cord injury (SCI) in the United States is reported at 
approximately 12,000 new cases per year, with a prevalence estimated at about 316,000 
people in 2010 (National Spinal Cord Injury Statistical Center, 2011).  This injury 
dramatically impacts the life of the affected individuals. Depending on the level and 
severity of the injury, SCI can result in partial or full paralysis, loss of bowel movement, 
loss of bladder and sexual function, and chronic pain.  Moreover, the cost of treatment 
for a patient with SCI, in the first year post injury, can go up to $985,774, and for the 
average patient, who experiences the injury at approximately 26 years of age, the 
lifetime cost of the injury is estimated to be around $4,373,912 (National Spinal Cord 
Injury Statistical Center, 2011). Given the high costs associated with SCI, both physical 
and economic, it is important that we better understand the factors contributing to a 
successful recovery. 
While recovery of lost physical function is a laudable goal, also important is 
improving the quality of life for people living with SCI.  As many as 60% of spinal cord 
injured patients suffer from depression (Shin, Goo, Yu, Kim, & Yoon, 2012), anxiety 
(Post & van Leeuwen, 2012), and general decreased quality of life (Boakye, Leigh, & 
Skelly, 2012). In a longitudinal study of 1035 spinal cord injured patients, 21% of 
patients met the criteria for major depressive disorder at one year following injury, and 
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18% at five years (Hoffman, Bombardier, Graves, Kalpakjian, & Krause, 2011).  Given 
the high percentage of spinal cord injured patients experiencing psychological 
symptoms, it is imperative that we better understand the mechanisms underlying 
decreased psychological well-being following SCI.  Yet, while there is considerable 
research focused on restoration of physical function, there is a surprising lack of basic, 
empirical research on psychological well-being post SCI. 
 Extensive research has been conducted in the clinical setting to understand the 
factors influencing psychological well-being following SCI. Clinical studies suggest that 
predictive factors include individual traits such as resilience, optimism, and neuroticism, 
as well as psychosocial factors, such as quality of life, loss of independence, social 
isolation, and financial hardships (Boakye et al., 2012; Boekamp, Overholser, & 
Schubert, 1996; Bombardier, Richards, Krause, Tulsky, & Tate, 2004; Botticello, Chen, 
Cao, & Tulsky, 2011; Botticello, Chen, & Tulsky, 2012; Chan, Lee, & Lieh-Mak, 2000a; 
Chang, Wang, Jang, & Wang, 2012; Elliott et al., 1991; Geyh et al., 2013; Guilcher et 
al., 2012; Jensen et al., 2014; Khazaeipour et al., 2014; Lohne & Severinsson, 2005; 
Peter, Rauch, Cieza, & Geyh, 2012; Post & van Leeuwen, 2012; Saunders, Krause, & 
Acuna, 2012; Schönenberg et al., 2012).  Importantly, however, although all spinal cord 
injured patients experience these hardships, to varying extents, not all spinal cord injured 
patients report decreased psychological well-being.  Studies repeatedly find that it is a 
sub-group of spinal cord injured patients who develop symptoms of depression or 
anxiety.  For example, a 10-year longitudinal study of 87 people with SCI found that a 
only a subset of participants showed signs of depressions throughout the years, and the 
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common characteristics of this sub-group were unclear (Pollard & Kennedy, 2007).  In 
fact, even when taking into account individual traits and psychosocial factors, 
psychological well-being following SCI cannot be clearly explained, or predicted. 
A compelling proposal is that, in addition to psychosocial stressors, the activation 
of the immune system resulting from the SCI itself may be contributing to the 
development of depression and anxiety following injury.  Support for this hypothesis is 
provided by both rodent and human studies (Maes, 1999; Miller, Haroon, Raison, & 
Felger, 2013; Smith, 1991; van West & Maes, 1999; Vogelzangs, Beekman, de Jonge, & 
Penninx, 2013).  In animal models for example, stressed rats were found to show 
increased spleen and brain (hippocampus, hypothalamus, and cortex) mRNA levels of 
pro-inflammatory cytokines relative to non-stressed rats (You et al., 2011).  
Furthermore, in rodent models, central or systemic administration of pro-inflammatory 
cytokines produces sickness behavior characterized by behavioral and physiological 
changes resembling depression (Anisman, Merali, Poulter, & Hayley, 2005), which can 
be alleviated with anti-depressants (Merali, Brennan, Brau, & Anisman, 2003). A 
number of human studies have also found an association between elevated levels of pro-
inflammatory cytokines and depression (Dowlati et al., 2010; Howren, Lamkin, & Suls, 
2009; Liu, Ho, & Mak, 2012) as well as anxiety (Miller et al., 2013; Pace & Heim, 
2011).  Given that pro-inflammatory cytokines are up-regulated following SCI (Yip & 
Malaspina, 2012), it is possible that immune system activation plays a pivotal role in the 
development of depression and anxiety following the trauma.  
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In this dissertation, we present experiments designed to test the hypothesis that 
changes in cytokine expression following SCI contribute to the development of an 
anxiety- and depression-like profile in contused rodents. The use of a rodent model of 
SCI is ideal for this purpose, as confounding psychosocial factors found in post SCI 
human studies, such as financial difficulties and loss of independence, are avoided.  In 
the animal model, therefore, we are able to focus on the specific effects that 
pathophysiological changes inherent to SCI have on psychological well-being.  
Furthermore, the rodent model of SCI allows us to study the effects of SCI on 
psychological well-being both at a behavioral level and a molecular level, examining 
cytokine expression in the periphery as well as in the brain post SCI.  
 In this introduction, we first review the definition of psychological well-being, 
depression and anxiety, and how immune changes are known to affect psychological 
well-being.  Next, we discuss mechanisms through which psychological well-being is in 
turn thought to affect the immune system.  Then, we review physiological changes 
following SCI which could potentially alter processes involved in psychological well-
being, with particular attention to the role of inflammation following the trauma, the 
focus of this dissertation.  Finally, we outline the specific aims of this dissertation.  
Defining psychological well-being 
Psychological well-being, for the purposes of this dissertation, is defined as the 
absence of depression and anxiety.  According to the DSM-IV-TR, the diagnostic 
criteria for major depressive disorder include “depressed mood and/or loss of interest or 
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pleasure in life activities for at least 2 weeks” and at least five of a list of symptoms 
including fatigue, inability to concentrate, suicidal ideation, depressed mood, inability to 
experience pleasure, noticeable psychomotor changes, changes in appetite or low self-
esteem (Center for Substance Abuse Treatment, 2008).  Our operational definition for 
depression-like behavior in rats is intended to mirror most of these symptoms and is 
taken from a previous study in the laboratory.  It includes anhedonia, psychomotor 
retardation, lack of interest in social interactions, and helplessness (Luedtke et al., 2014).  
According to the APA, “Anxiety is an emotion characterized by feelings of tension, 
worried thoughts and physical changes like increased blood pressure” (American 
Psychological Association, 2014).  Our operational definition for anxiety-like behavior 
in rats includes active anxiety, which is characterized by fight or flight behavior, and 
passive anxiety, which is characterized by withdrawal behavior (Steimer, 2011).  
Throughout this dissertation, we use tests designed to assess these behaviors in order to 
evaluate psychological well-being.  
At a molecular level, major depressive disorder is commonly defined as a 
monoamine dysregulation disorder in which brain levels of serotonin, norepinephrine, 
and dopamine levels are altered (Saveanu & Nemeroff, 2012).  Post-mortem studies of 
suicide victims and positron emission tomography studies of depressive patients have 
shown that serotonin depletion in the central nervous system is strongly associated with 
the development of depression (Drevets et al., 1999; Mann et al., 1996).  Furthermore, 
the most common and generally successful treatment for depression is the administration 
of selective serotonin-reuptake inhibitors (SSRIs), which increase the availability of 
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serotonin at synaptic clefts.  However, it is now accepted that decreased serotonin levels 
do not explain depressive symptoms in all patients (aan het Rot, Mathew, & Charney, 
2009).  Indeed, research also suggests a role for norepinephrine in depression (Ressler & 
Nemeroff, 2001).  Patients suffering from major depressive disorder exhibit altered 
levels of cerebrospinal fluid norepinephrine (Saveanu & Nemeroff, 2012), and post-
morterm studies have found increased expression of adrenergic receptors in suicide 
victims (Sastre, Guimon, & Garcia-Sevilla, 2001). In addition, some studies suggest that 
patients who do not respond well to the common SSRIs can benefit from antidepressants 
that act both on serotonin and norepinephrine (Horst & Preskorn, 1998).  Furthermore, 
dopamine is also considered to be involved in the pathophysiology of clinical 
depression.  For example, a positron emission tomography study comparing dopamine 
binding potential in the striatum of depressed and healthy participants found that 
depressed individuals show reduced dopamine binding potential (Meyer et al., 2001). It 
has been suggested that treatments promoting dopamine neurotransmission may provide 
positive results in patients who do not respond well to SSRI treatment (Saveanu & 
Nemeroff, 2012).  Finally, Nutt (2008) has suggested that these three neurotransmitters 
may be responsible for different symptoms of depression.  Low levels of serotonin may 
explain anxiety; low levels of norepinephrine may be linked to reduced energy and 
interest in pleasurable activities; and low levels of dopamine  may explain decreased 
motivation and interest in rewards (Nutt, 2008).  These studies underscore the 
complexity of the mechanisms underlying the development and maintenance of 
depression.   
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Over the last decades, in addition to serotonin, norepinephrine, and dopamine, 
other signaling molecules implicated in the pathophysiology of depression have been 
identified, such as the brain-derived neurotrophic factor (BDNF) and the nerve growth 
factor (NGF) (Banerjee, Ghosh, Ghosh, Bhattacharyya, & Mondal, 2013; de Azevedo 
Cardoso et al., 2014; Satomura et al., 2011).  Both central and peripheral decreases in 
BDNF levels have been found in depressed individuals.  Banerjee et al. (2013) compared 
postmortem levels of BDNF and NGF in the hippocampi of depressed individuals who 
committed suicide to those of individuals who died from natural causes.  The results 
were conclusive: ELISAs, Western Blots and rt-PCR all indicated that BDNF and NGF 
levels were decreased in the suicide victims relative to the comparison group.  Likewise, 
serum levels of BDNF and NGF have been found to be decreased in individuals 
suffering from major depressive disorder, relative to healthy individuals (de Azevedo 
Cardoso et al., 2014; Satomura et al., 2011).  It is important to note, however, that these 
studies were conducted with individuals who were already depressed at the time of 
analyses.  Given these experimental constraints, we cannot determine with certainty 
whether these neurotrophic factors are a cause, or a consequence of depression.  
Nonetheless, their association with depression is clear, and these data provide evidence 
that molecules beyond the monoamines are involved in major depressive disorder.  
Similarly, another family of molecules implicated in depression, and for which perhaps 
even stronger evidence exists, are the cytokines and inflammation-related molecules.  
The following sections review the evidence implicating cytokines in the development of 
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both depression and anxiety, and discuss the implications of an inflammatory-mediated 
sub-type of depression in the context of SCI. 
The role of the immune system in psychological well-being 
There is a growing body of literature, both human and animal, pointing to a role 
for chronic peripheral and central inflammation in major depressive disorders, anxiety, 
and even schizophrenia (Anisman, 2009; Black & Berman, 1999; Dantzer, O'Connor, 
Freund, Johnson, & Kelley, 2008; Felger & Lotrich, 2013; Maes, 1999; Muller, 2013; 
Pace & Miller, 2009; Rosenblat, Cha, Mansur, & McIntyre, 2014; Uddin et al., 2011; 
Wager & Gianaros, 2014; Walker, Kavelaars, Heijnen, & Dantzer, 2014; Zunszain, 
Hepgul, & Pariante, 2012).  The literature on the association between inflammation and 
depression specifically, includes both experimental and clinical evidence.  For example, 
a double-blind, crossover study of 20 healthy male participants found that immune 
activating agents such as endotoxins can induce transient depressive-like symptoms 
(Reichenberg et al., 2001).  Likewise in rats, administration of LPS or other immune 
agents has consistently been shown to induce depression-like signs, such as increased 
learned helplessness (Makino, Kitano, Komiyama, & Takasuna, 2000) and anhedonia 
(De La Garza, 2005) in the hours following the treatment.  Furthermore, in the clinical 
setting, immunotherapy has been repeatedly been found to induce depression symptoms 
in cancer patients (Dantzer et al., 2008).  Up to 30 to 50% of patients undergoing 
interleukin-2 (IL-2) or interferon-α (IFN-) therapy for cancer or hepatitis C develop 
marked symptoms of depression and anxiety (Capuron, Ravaud, Miller, & Dantzer, 
2004; Musselman et al., 2001).  An emerging literature also highlights an association 
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between inflammation and anxiety (Salim, Chugh, & Asghar, 2012).  For example, in a 
mouse model of premature aging, high levels of anxiety have been found to be 
associated with chronic inflammation (Vida, Gonzalez, & Fuente, 2014).  Activation of 
the innate immune system, particularly increases in brain interferon-1β (IL-1β) levels, 
augment anxiety-like behaviors in the open-field test and the elevated plus maze test 
(Chiu et al., 2014).  Similar evidence exists in humans. For example, Pitsavos et al. 
(2006) demonstrated, in a cross-sectional study, that high levels of C-reactive protein 
levels (a biomarker of inflammation) are positively correlated with anxiety in healthy 
individuals.  These findings highlight the critical relationship between altered immune 
function and symptoms of depression and anxiety.   
Although the exact mechanism through which inflammation may affect mood is 
not known, several potential mechanisms have been suggested.  Three major 
pathophysiological mechanisms are the cytokine hypothesis, the hypothalamic-pituitary-
adrenal (HPA) axis hypothesis, and the microglial hypothesis. 
The cytokine hypothesis 
The cytokine hypothesis proposes that cytokines are directly involved in 
inducing depression.  Cytokines such as IL-2, IFN-γ, tumor necrosis factor-α (TNF-α), 
and interleukin-6 (IL-6) are known to increase the enzymatic activity of indolamine 2,3-
dioxygenase (IDO) (Maes, Leonard, Myint, Kubera, & Verkerk, 2011; Roman, Kreiner, 
& Nalepa, 2013).  This enzyme, in turn, acts as a catalyst for the conversion of 
tryptophan, the precursor for serotonin, into kynurenine, whereby levels of tryptophan 
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available are decreased, and, consequently too, the levels of serotonin that can be 
produced (Capuron et al., 2003; Capuron et al., 2001).  By promoting the conversion of 
tryptophan into kynurenine, therefore, cytokines contribute to serotonin depletion and, if 
not to the development of depression, at the very least to its maintenance.  In addition, 
cytokines can also facilitate the breakdown of existing serotonin.  Cytokines such as IL-
6 and TNF-α, assist in the breakdown of 5-Hydroxytryptophan (5-HT) into 5-
Hydroxyindoleacetic acid (5-HIAA).  In sum, cytokines not only reduce the amount of 
serotonin produced, but can also increase the amount of serotonin degraded, thus 
contributing to the development of depression through two pathways.  
Cytokines can also alter the synthesis of catecholamines.  For example, pro-
inflammatory cytokines such as IFN-γ generally trigger the synthesis of 5,6,7,8-
tetrahydrobiopterin (BH4), a co-factor for enzymes (phenylalanine and tyrosine) that 
synthesize the precursors for dopamine, norepinephrine, and epinephrine.  However, 
IFN-γ also prompts macrophages to release reactive oxygen species, which degrade 
BH4.  Therefore, some have suggested that chronic inflammation may cause a decreased 
availability of BH4, which would result in lower levels of catecholamine production in 
the long-term (Sperner-Unterweger, Kohl, & Fuchs, 2014). This could explain altered 
epinephrine and norepinephrine levels in patients with some forms of depression.  
The hypothalamic-pituitary-adrenal axis hypothesis 
Whereas the cytokine hypothesis supposes a direct relationship between 
cytokines and serotonin levels, the HPA axis hypothesis suggests that increased levels of 
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cytokines such as interleukin-1 (IL-1), IL-6, TNF-α and IFN-γ contribute to the 
development of depression via activation of the HPA axis and the alteration of 
glucocorticoid levels. It is known that individuals with depression exhibit increased 
activation of the HPA axis as well as high levels of circulating glucocorticoids 
(Holsboer, 2000; Pariante & Miller, 2001).  Given the usual anti-inflammatory role of 
glucocorticoids, this initially appears contradictory to the argument that inflammation is 
involved in depression.  In reality, however, the two are supporting evidence for the role 
of cytokines in depression.   
Cytokines activate the HPA axis, and this results in increased production of 
glucocorticoids (Rosenblat et al., 2014).  Chronically increased levels of cytokines can, 
in this manner, induce glucocorticoid resistance, which is characterized by the decreased 
expression of glucocorticoid receptors, as well as decreased sensitivity and function of 
the glucocorticoid receptors (unable to translocate from the cytoplasm to the nucleus) 
(Pace, Hu, & Miller, 2007).  This decrease in glucocorticoid receptor function in turn 
prevents glucocorticoids from exerting their anti-inflammatory effects (Pace & Miller, 
2009).  Therefore, as a result of chronically elevated circulating glucocorticoids and the 
glucocorticoid resistance that ensues, cytokine levels continue to increase, thus further 
activating the HPA axis and increasing levels of glucocorticoids produced by the adrenal 
glands, perpetuating this cycle.  Furthermore, glucocorticoids normally function in a 
negative neuroendocrine feedback loop; high plasma levels signal the hypothalamus to 
stop producing corticotropic-releasing hormone (CRH), and signal the anterior pituitary 
to stop producing adrenocorticotropic hormone (ACTH).  With glucocorticoid 
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resistance, this normal feedback inhibition is lost, and glucocorticoids continue to be 
produced.  The increase in glucocorticoids due to glucocorticoid resistance not only 
activates the stress response (Maldonado Bouchard & Hook, 2014) but also plays a 
direct role in depression.  Specifically, glucocorticoids can increase levels of the hepatic 
enzyme tryptophan 2,3-dioxygenase (TDO).  TDO is a powerful catabolic enzyme of 
tryptophan and, similar to IDO, increased levels of TDO lead to tryptophan depletion, 
which results in decreased levels of serotonin production, and increased levels of 
tryptophan catabolites (Maes et al., 2011; Wolf, 1974).  Chronic HPA axis activation can 
therefore both result from depression, and contribute to perpetuating depression (Figure 
1). 
 
 
 
 
  
Figure 1- Suggested mechanism for role of inflammation and HPA axis in depression. 
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The microglial hypothesis 
Finally, cytokines are also thought to be involved in depression indirectly, via 
microglial activation. Studies have recently uncovered the role of quiescent microglia in 
the phagocytic engulfment of neuronal synapses in healthy brains (Tremblay & 
Majewska, 2011).  Using electron microscopy and two-photon in vivo imaging, 
Tremblay et al. (2011) demonstrated that even normal visual stimuli influence microglial 
behavior in the visual cortex of mice, increasing phagocytic engulfment of synapses.  
These types of changes in plasticity are accentuated following an innate immune 
response.  Cytokines, such as TNF-α and IL-1β activate microglia, resulting in increased 
phagocytic engulfment of synapses (Park & Bowers, 2010).  This is thought to lead to 
synaptic pruning, a regulatory process whereby neurons and synapses are eliminated to 
the benefit of fewer, more efficient connections (Miyamoto, Wake, Moorhouse, & 
Nabekura, 2013).  When inflammation becomes chronic, however, microglia remain 
activated, constantly producing cytokines. The constant production of pro-inflammatory 
cytokines can inhibit neurogenesis, lead to neurotoxicity, and further microglial 
activation (Ekdahl, 2012; Rosenblat et al., 2014; Stertz, Magalhaes, & Kapczinski, 
2013).  Consistent with this hypothesis, increases in microglial activation has been found 
in the prefrontal cortex of individuals with bipolar disorder (Stertz et al., 2013).  
Furthermore, individuals with major depressive disorder frequently show decreased 
hippocampal volume (Bremner et al., 2000; Campbell, Marriott, Nahmias, & MacQueen, 
2004; Duman, Malberg, & Thome, 1999; Frodl et al., 2002; MacQueen et al., 2003; 
Mervaala et al., 2000; Paradise, Naismith, Norrie, Graeber, & Hickie, 2012; Stockmeier 
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et al., 2004). Comparing the hippocampal volume of individuals with major depressive 
disorder versus normal controls, Stockmeier et al. (2004) found that depressed 
individuals showed decreased hippocampal volume overall, with up to a 35% increase in 
glial cells in the same region. This decrease in hippocampal volume is suggested to be 
due to a decrease in synaptic connections, which, possibly, is due to increased microglial 
activation.  Through chronic activation of microglia, cytokines can establish a vicious 
circle, in which continued cytokine production results in further activation of microglia, 
in addition to affecting the HPA axis, and serotonin levels, as seen in the two previous 
sections.  
The effect of psychological well-being on the immune system 
Not only can immune system dysregulation play an important role in modulating 
psychological well-being, but psychological well-being can in turn influence the immune 
system.  A variable frequently used to study this relationship is chronic social stress.  It 
is well established that chronic social stress can lead to a blunted glucocorticoid response 
and an elevated immune response, both in rodents and humans (Avitsur, Powell, Padgett, 
& Sheridan, 2009; Miller et al., 2008; Powell et al., 2013).  In mice, repeated social 
defeat has been shown to lead to glucocorticoid resistance and an increased 
inflammatory response (Avitsur et al., 2009; Avitsur, Stark, & Sheridan, 2001; Powell et 
al., 2013; Stark et al., 2001).  In humans, chronic social stress in the form of low 
socioeconomic status has been shown to be associated with the greater presence of 
immature pro-inflammatory monocyte transcriptome in peripheral blood mononuclear 
cells (Powell et al., 2013).  Examining fear of terrorism as a form of social stress, 
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Melamed et al. (2004) also found that fear was positively correlated with elevated C-
reactive protein levels in employed Israeli adult women.  These data suggest that 
psychological well-being can significantly modulate physiological function. 
Another variable used to study low psychological well-being is social isolation 
(in animal models) or perceived loneliness (in human studies). In rats, social isolation 
can increase levels of the adrenocorticotropic hormone, as well as alter the immune 
response.  For example, Krügel et al (2014) found that single-housed rats, relative to rats 
housed in groups of four, showed increased levels of adrenocorticotropic hormone, TNF-
α, interleukin-4 (IL-4) and interleukin-10 (IL-10).  In turn, in a large study of 5000 
ageing adults (50 years or older), Shankar et al. (2011) found that perceived social 
isolation was positively correlated with high levels of C-reactive protein.  Similarly, 
Jaremka and colleagues (2013) have found that both healthy adults and posttreatment 
breast-cancer survivors who showed greater perceived loneliness as per the UCLA 
Loneliness Scale exhibited a stronger immune response following an acute stressor 
(delivering a five minute speech in front of an audience) than participants who showed 
lower perceived loneliness.  Specifically, the peripheral blood mononuclear cells of the 
participants who exhibited high perceived loneliness showed greater production of TNF-
α and IL-6 when stimulated with lipopolysaccharide in culture, than did the cells of 
participants who showed lower perceived loneliness (Jaremka et al., 2013).  Moreover, 
Cole et al. (2007) have shown that individuals who experience high levels of loneliness 
have an up-regulation of genes involved in pro-inflammatory processes, and a down-
regulation of genes involved in anti-inflammatory processes, such as the genes 
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responsible for the glucocorticoid response. The results from the studies reviewed above 
provide supporting evidence for the proposal that inflammation can be both a cause and 
a consequence of decreased psychological well-being.  
Changes post spinal cord injury relevant to psychological well-being 
As seen in the sections above, decreased psychological well-being can be 
attributed to various processes, three of which are changes in cytokine levels, alteration 
of the HPA axis, and changes in microglia.  Importantly, SCI also affects these three 
systems.  In the following paragraphs, we review how these three systems are impacted 
following a SCI.  We combine the microglia and immune system changes as these two 
are closely interrelated in SCI. 
Spinal cord injury causes changes to microglia and the immune system 
Following the injury, microglia, macrophages, and astrocytes are recruited to the 
site of trauma. Glial cells (microglia, astrocytes, and oligodendrocytes) are vital to 
neuronal function (Carson, Thrash, & Walter, 2006), and one of their key roles is 
maintaining homeostasis (Barres, 2008).  They regulate the levels of excitatory amino 
acids, such as glutamate, and the pH of the synaptic interstitial fluid (Carson et al., 2006; 
Sofroniew & Vinters, 2010).  Microglia, specifically, are the macrophages of the central 
nervous system and serve as resident immune cells (Carson et al., 2006; Hulsebosch, 
2002) and they are beneficial in the regulation of homeostasis after SCI.  Pathologically, 
however, they also release pro-inflammatory cytokines and this may adversely affect 
psychological well-being.  Pro-inflammatory cytokine genes and other inflammation-
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related genes are up-regulated within hours of injury (Dumont et al., 2001; Yip & 
Malaspina, 2012).  For example, in the hours following injury, the interleukin-6 gene, 
the TNF gene, and the interleukin-1β gene are up-regulated (Hayashi, Ueyama, Nemoto, 
Tamaki, & Senba, 2000; Pan et al., 2002).  The levels of cytokines such as IL-6, IL-1β, 
IL-1α, and TNFα have also been shown to increase in contused subjects, peaking at 
approximately 6 hours post SCI, and returning to near basal levels by 24 hours post SCI 
(Stammers, Liu, & Kwon, 2012; Yang et al., 2005).  In addition to this early phase of 
inflammation, long-term cellular inflammation also occurs post SCI.  Using flow 
cytometry in the injured spinal cord, Beck et al. (2010) demonstrated that starting at 14 
days post injury, T cells, microglia and neutrophils increase in the spinal cord, and are 
detectable up to 180 days post injury (Beck et al., 2010).  Thus, SCI results in increased 
immune activity at the level of the spinal cord both immediately after the injury, and in 
the days and even weeks following it. 
These changes in pro-inflammatory cytokine expression are not restricted to the 
injury site. Elevated serum levels of pro-inflammatory cytokines have also been found in 
patients with chronic SCI (Davies, Hayes, & Dekaban, 2007; Hayes et al., 2002), as well 
as in animal models of SCI (Hasturk et al., 2009). As early as the 1990s, SCI researchers 
suggested that cytokine dysregulations may be involved in SCI secondary complications 
such as pressure ulcers (Segal, 1992).  Later, studies examined cytokine levels in spinal 
cord injured patients suffering from pressure ulcers, and found that actually, all spinal 
cord injured patients, regardless of whether they experienced secondary complications or 
not, exhibited higher levels of cytokines (IL-6, IL-2R and intracellular adhesion 
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molecular 1) than healthy controls (Segal, Gonzales, Yousefi, Jamshidipour, & 
Brunnemann, 1997).  Since then, additional studies have examined more closely the 
changes in cytokine levels post SCI in patients without medical complications. Hayes et 
al. (2002) found that spinal cord injured patients (n=24) showed increased levels of IL-2 
and TNF-α compared to healthy controls (n=26), but no differences for levels of IL-4 or 
IL-10.  Moreover, they found that 57% of the patients showed such increases, suggesting 
that it is a subset of spinal cord injured patients that shows chronic immune system 
activation post SCI (Hayes et al., 2002).  Another recent cross-sectional study comparing 
56 patients with SCI with 35 control participants, confirmed that even asymptomatic 
patients (no medical complications such as neuropathic pain, pressure ulcers or 
infections) displayed higher levels of IL-6, TNF-α, and IL-1ra than the non-injured 
control participants (Davies et al., 2007).  These findings suggest that SCI itself, not the 
secondary complications, have an immune activation effect in the periphery.  
Pro-inflammatory signals produced in the periphery can reach the brain via a 
number of routes: (1) active transport-they can be transported from the peripheral 
circulation to the brain via specific transporters; (2) leaky blood-brain barrier- at sites of 
fenestration or as a result of illness; (3) macrophage activation- activation of 
macrophages and endothelial cells lining the cerebral vasculature; (4) directly from the 
blood (Roman et al., 2013).  To the best of our knowledge, changes in brain cytokines 
post SCI have not been studied.  However, given the ruptured blood-brain barrier 
resulting from SCI, the various routes through which peripheral cytokines can reach the 
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central nervous system and the fact that peripheral cytokine levels are altered post SCI, it 
is likely that changes in these cytokines occur in the brain as well.  
Spinal cord injury causes hypothalamic-pituitary-adrenal axis changes 
A great deal is known about the effects of synthetic glucocorticoids on SCI, but 
less is known about how SCI affects endogenous glucocorticoids and the HPA axis.  
Nonetheless, some clinical and case studies have demonstrated that SCI can alter the 
HPA axis, both in the acute and the chronic phase of injury (Huang, Wang, Lee, & Lai, 
1998; Lee et al., 2002; Lerch, Puga, Bloom, & Popovich, In Press).  For example, Huang 
et al. (1998) assessed functioning of the HPA axis following SCI by comparing plasma 
levels of corticotrophin-releasing hormone and insulin-induced hypoglycemia in spinal 
cord injured patients versus healthy controls. Overall, spinal cord injured patients 
exhibited alterations of the HPA axis, such as decreased adrenocorticotropic hormone 
and cortisol release following insulin-induced hypoglycemia and corticotropin-releasing 
hormone relative to healthy controls, thus indicating a blunting of the HPA axis.  Long-
term abnormal adrenocorticotropin secretion may cause mild adrenocortical atrophy and, 
thereby, a reduced cortisol response.  Lee et al. (2002) also examined adrenal gland 
volume post SCI.  Using computed tomographic imaging to conduct volumetric 
measurements of adrenal glands, they compared the adrenal glands of chronic spinal 
cord injured patients with impaired adrenal reserve, to those of healthy controls.  The 
adrenal glands of the spinal cord injured patients, on average, were found to be larger 
than those of the healthy controls, even after controlling for patients’ height and weight .  
Adrenal gland volume is known to increase with depression, becoming up to 70% larger 
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in patients with depression versus healthy individuals (Rubin, Phillips, Sadow, & 
McCracken, 1995), and it thought to be due to hyperactivity of the pituitary-
adrenocortical axis.  Given the enlarged adrenal glands observed in chronic spinal cord 
injured patients, it is possible that such hyperactivity also play a role in depression post 
SCI.  
A few studies have also shown that changes in glucocorticoid expression 
specifically occur following SCI.  Using a rodent model of SCI, Popovich et al. (2001) 
found that serum corticosterone levels increased within 24 hours following SCI and 
remained elevated for at least one month post injury. Importantly, sham subjects did not 
show this elevation (Lucin, Sanders, Jones, Malarkey, & Popovich, 2007; Popovich et 
al., 2001).  Similar results have been found in humans.  In a study of 54 spinal cord 
injured patients, urine cortisol and plasma adrenocorticotropin hormone levels were 
shown to be increased relative to non-injured patients, two weeks following injury 
(Cruse et al., 1993). It is thought that these changes in glucocorticoid expression post 
SCI may affect numerous cellular and physiological processes, such as apoptosis and 
inflammation (Lerch et al., In Press).   
To the best of our knowledge, changes in brain glucocorticoid levels post SCI 
have not been studied.  However, we know that the blood-brain barrier is ruptured as a 
result of SCI (Sharma, 2005; Whetstone, Hsu, Eisenberg, Werb, & Noble-Haeusslein, 
2003), that glucocorticoids can cross the blood-brain barrier (Karssen, Meijer, & de 
Kloet, 2005), and that the level of urine glucocorticoids increase post SCI (Cruse et al., 
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1993).  It is, therefore, possible that brain levels of glucocorticoids are increased by SCI.  
Moreover, given that elevated serum glucocorticoids are maintained at least for a month 
following SCI, chronic elevation of glucocorticoids may also occur in the brain, which 
could result in the development of glucocorticoid resistance, sustained inflammation, 
and eventually, cytokine-induced depression.   
Spinal cord injury causes changes in neurotransmitter and neurotrophic systems 
involved in psychological well-being 
SCI also causes alterations in neurotransmitter and neurotrophic systems that 
have been implicated in psychological well-being.  In the 1970s and 80s, several 
laboratories studied changes in the levels of serotonin, norepinephrine and dopamine 
post SCI, with contradictory results.  Osterholm et al. (1972) assessed the levels of 
monoamines post SCI in cats, hypothesizing that these neurotransmitters could act as 
mediators in secondary damage following SCI.  Using spectrofluorometric analyses, 
they observed that spinal cord norepinephrine levels increased within 30 minutes of SCI, 
began decreasing at 3 hours post, and were below baseline levels 24 hours post.  
Dopamine displayed an opposite pattern: spinal cord levels of dopamine decreased 
within 30 minutes, and remained so for 24 hours post SCI.  No spinal cord serotonin 
level changes were observed (Osterholm & Mathews, 1972).  However, since then, 
contradictory results have been reported.  For example, Naftchi et al. (1974) found no 
changes in norepinephrine and increases in dopamine, and Rodriguez et al. (1977) 
observed increases in dopamine and norepinephrine above the lesion in spinal cord 
sections collected 7 days after a transection injury, and decreases in the same 
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neurotransmitters below the lesion.  In the 90s, microdialysis studies resolved some of 
the contradictions of earlier studies by collecting data across time post injury.  Levels of 
norepinephrine and serotonin were recorded in the spinal cord (Liu, Valadez, Sorkin, & 
McAdoo, 1990).  Supporting the original findings of Osterholm et al. (1972),  Liu et al. 
(1990) observed increased norepinephrine shortly after SCI.  In addition, they noted 
substantial increases in serotonin in the 30 to 45 minutes following SCI.  Despite the 
different reports over the years, what these studies highlight is the impact of SCI on 
neurotransmitter systems at the level of the spinal cord, in the acute phase of injury.  
Further, in a unique study, Naftchi et al. (1981) examined post SCI monoamine 
levels in the heart, adrenal glands, and brainstem of paraplegic rats.  To the best of our 
knowledge, this is the only study having assessed levels of all three monoamines in 
organs other than the spinal cord following SCI.  They reported 30 to 60% decreases in 
heart norepinephrine and serotonin levels 24 hours post SCI in transected animals 
relative to shams. They also reported increased norepinephrine and serotonin levels in 
the brainstem of transected animals 7 days following SCI relative to shams (Naftchi et 
al., 1981).  This study provides strong evidence that SCI can affect neurotransmitter 
systems in organs beyond the spinal cord itself. 
Based on the current data available, it is unclear how these changes in spinal cord 
monoamine levels post SCI affect psychological well-being, if at all.  Most of the 
changes discussed above appear to be transient- lasting at the most a few days.  Longer-
term changes in spinal cord monoamines post SCI, as far as we know, have not been 
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investigated.  The results of the study by Naftchi et al. (1981) do suggest that levels of 
serotonin and norepinephrine increase supraspinally, at least a week post injury.  
Paradoxically, this would, in theory, be associated with decreased depressive symptoms.  
It may be that these increases in serotonin are not sufficient to modulate psychological 
well-being, or that they do not affect brain levels.  Brain levels of serotonin post SCI 
remain unknown.  One human study published in 1998, however, looked at serum levels 
of serotonin pre and post exercise in paraplegic patients.  This was done to assess 
whether chronic spinal cord injured patients experienced serotonergic dysregulations or 
not.  Following exercise, increases in serotonin are expected, and in this sample, chronic 
spinal cord injured patients exhibited increases in serum serotonin levels post exercise, 
thus indicating normal serotonergic responses.  This suggests to us that changes in 
serotonin at the level of the spinal cord in the acute phase post SCI likely do not affect 
peripheral serotonin levels in the long-term.   
In addition to altering neurotransmitter concentration at the level of the spinal 
cord, SCI also results in decreased expression of members of the neurotrophin family.  
Certain studies report that SCI decreases NGF, BDNF and neurotrophin-3 (NT-3) 
expression at the level of the spinal cord (Hajebrahimi, Mowla, Movahedin, & Tavallaei, 
2008), whereas others have mostly observed decreases in BDNF (Hyun, Lee, Son, & 
Park, 2009).  Decreased BDNF expression has also been shown in the hippocampus of 
spinally contused rats, from one week to a month post SCI (Fumagalli et al., 2009).  
Sprague-Dawley male rats were contused, laminectomized only, or intact.  At 24 hours 
or 28 days post injury, they were sacrificed and brain tissue (prefrontal cortex, frontal 
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cortex, and hippocampus) was collected for RNAase Protection Assays. mRNA levels of 
BDNF were assessed, as well as mRNA levels of the trophic factor fibroblast growth 
factor 2 (FGF-2) and growth associated protein 43 (GAP-43), for comparison.  Results 
revealed that although there was an initial (first 24 hours) decrease in BDNF in all brain 
areas studied, levels returned to normal in all areas except the hippocampus.  Moreover, 
the authors suggested that the fact that levels of FGF-2 and GAP-43 remained 
unchanged following SCI provided initial evidence that the decreased expression post 
SCI was selective for BDNF.  As discussed earlier, serum and brain levels of BDNF and 
NGF are decreased in depressed individuals. Although it is not currently known whether 
these neurotrophic factors cause depression or vice-versa, it is worth considering that 
decreases in BDNF and NGF levels due to SCI may contribute to the pathophysiology of 
depression following the injury.  Fumagalli et al.’s results provide unique empirical 
evidence that SCI not only affects the spinal cord physiology, but also the brain.  Given 
the ruptured blood-brain barrier resulting from SCI, and the fact that BDNF changes 
have been confirmed in the brains of contused rats, it is possible that other changes at the 
level of the spinal cord also influence the brain.   
While SCI is known to cause changes in serotonin, norepinephrine and 
dopamine, as well as glucocorticoids and cytokines, at the level of the spinal cord, the 
evidence for supraspinal effects is limited. Future studies must assess changes in the 
supraspinal levels of the molecules post SCI to delineate possible mechanisms associated 
with decreased psychological well-being following injury. 
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Specific aims 
Approximately 60% of depressed patients do not respond well to traditional 
antidepressant medications based on SSRIs (Cattaneo et al., 2013; Krishnadas & 
Cavanagh, 2012; Mathew & Charney, 2009). As reviewed in the earlier sections, there is 
increasing evidence suggesting that in a subset of patients with depression, the etiology 
of the disorder involves dysregulation of the immune system (Maes, 1999; Smith, 1991).  
This is of particular relevance for spinal cord injured patients, for we know that 
important immune changes occurs in the spinal cord following SCI.  Nonetheless, the 
effects of SCI on supraspinal levels of cytokines and psychological well-being remain 
unknown.  Our experiments are designed to address this. 
We propose that SCI, by activating the immune system, may hinder 
psychological well-being, potentiating the development of depression and anxiety-like 
signs post injury. We further suggest that psychological well-being may in turn influence 
the physical course of recovery by modulating immune system activation in the long-
term. We recognize that individual factors (i.e., pain reactivity, resilience to stress) may 
interact with SCI to cause individual variations in pro-inflammatory cytokine expression 
that affect psychological well-being. However, identifying these factors is beyond the 
scope of this proposal.  Instead, as an initial step, we aim to test the hypothesis that 
changes in pro-inflammatory cytokine expression potentiate the development of 
behavioral changes indicative of depression and anxiety in the rodent SCI model and 
examine whether these changes in turn affect SCI recovery. 
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Specifically, the experiments proposed here are designed to determine whether 
SCI affects psychological well-being and also to explore the reverse relationship; 
whether psychological well-being affects SCI.  In two pilot studies in our lab, we found 
that two forms of external psychological stress (sound stress and uncontrollable 
electrical stimulation) did not significantly decrease psychological well-being following 
SCI.  We suspected this to be due to the fact that SCI itself is a strong stressor, and is 
masking the effect of any other additional external stressor.  To investigate this, we have 
designed the experiments reported in Chapter III and IV.  The experiment described in 
Chapter III assesses the effects of SCI on psychological well-being at the behavioral 
level.  The experiment reported in Chapter IV is designed to evaluate, at the molecular 
level, the role of the inflammatory response as a function of injury severity in the 
development of depression and anxiety-like signs post SCI.  Lastly, in another pilot 
study in our lab, we have found that social housing diminishes the negative effects of 
uncontrollable electrical stimulation on locomotor recovery of function.  Consequently, 
in Chapter V, we conduct an experiment to test the potential beneficial effects of social 
housing in protecting from decreased psychological well-being post SCI and, as a result, 
perhaps also promoting physical recovery in our rodent SCI model. 
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CHAPTER II  
GENERAL METHODS 
 
Subjects 
Male Sprague-Dawley rats obtained from Harlan (Houston, TX), approximately 
90-110 days old (300-350 g) were individually housed in Plexiglas bins [45.7 (length) x 
23.5 (width) x 20.3 (height) cm] with food and water continuously available. The rats 
were maintained on a 12 hour light/dark cycle and all behavioral testing was conducted 
during the light cycle. Food consumption and subject weights were recorded daily. 
Following surgery, subjects were manually expressed in the morning (8-9:30 a.m.) and 
in the evening (6-7:30 p.m.) until they regained full bladder control (which was 
operationally defined as three consecutive days with an empty bladder at the time of 
expression), and were checked daily for signs of autophagia and spasticity.  
All of the experiments reported here were reviewed and approved by the 
Institutional Animal Care Committee at Texas A&M University and all NIH guidelines 
for the care and use of animal subjects were followed. 
Surgery 
An Infinite Horizons (IH) impactor (Precision Systems and Instrumentation) 
fitted with a 2.5 mm impact probe was used to deliver a contusion injury to the T12 
spinal cord.  Subjects were anesthetized with 5% isoflurane gas, and once a stable level 
of anesthesia was reached, the concentration was lowered to a 2-3% maintenance 
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level.  While under stable anesthesia, an area extending approximately 2.5 cm above and 
below the injury site was shaved and disinfected with iodine.  A 3-4 cm incision was 
made in the skin along the midline of the animal, followed by 1.5 cm incisions on either 
side of the spinous process at the level of injury.  A laminectomy was performed 
removing the T12 vertebra and exposing the spinal cord.  The animal was fixed in the 
impactor and the probe exerted a force onto the cord, remaining in contact with the cord 
for one second (dwell time).  Depending on the experiment, a force of 110 kDynes for a 
mild injury, 150 kDynes for a moderate injury, or 200 kDynes for a severe injury was 
applied to the cord.  Immediately after the contusion, the incision was closed with 
Michel clips and subjects were treated with 100,000 units/kg Pfizerpen (penicillin G 
potassium), both immediately following surgery and again two days later, to help 
prevent infection.  To compensate for fluid loss, subjects received 3.0 ml of filtered 
saline at the time of surgery and again two days later.  In addition, rats were kept in a 
recovery room (maintained at 26.6°C) for 24 hours following the injury. 
Behavioral tests 
Assessment of psychological well-being 
Anhedonia 
The sucrose preference test was used to assess anhedonia. The test was 
conducted in the home cage, from 14:00 to 16:00. For testing, one pre-weighed water 
bottle filled with approximately 250 ml of 2% sucrose solution and one pre-weighed 
bottle filled with an equal amount of water were placed on either side of the subject’s 
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cage, and left for two hours. The placement of the sucrose and the water solutions (on 
either the left or right sides) was counterbalanced between subjects and across testing 
periods. The position of the bottle in the cage (left/right) was also reversed after one 
hour, to prevent any positional biases from confounding results. At the end of the test 
period, the change in the weight of each bottle of solution was determined. Sucrose 
preference (SP) was then calculated using the following formula: %SP = [sucrose 
solution intake (g) / (sucrose solution intake (g) + water intake (g))] X 100 (Wang et al., 
2009).  
Subjects were acclimated to the sucrose preference test in three sessions 
beginning 13 days prior to surgery. Baseline preferences were collected five days prior 
to surgery. Sucrose preference was then measured during Test Phase 1 and 2 post injury, 
on Days 10 and 21 post SCI. A decrease in sucrose preference is a sign of anhedonia, or 
lack of ability to experience pleasure (Luedtke et al., 2014). 
Psychomotor activity and center field activity 
The open field test was used to assess psychomotor activity and center field 
activity.  The test was conducted in a black plywood box [100 (length) x 20 (height) x 
100 (width) cm], from 8:00 to 11:00. The floor of the box was partitioned into 100 
squares [10 (length) x 10 (width) cm] delineated with silver marker. A layer of clear 
Plexiglas was used to cover the top of the box. The testing room was dark and the open 
field environment was illuminated from above by a 60 W white light. Subjects were 
acclimated to the testing room (in their transport boxes) for ten minutes prior to testing. 
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Following the acclimation period, the subject was placed in the center of the plywood 
box to begin a five-minute test session. Between each trial, the open-field environment 
was cleaned with Nolvasan to eliminate any olfactory cues. The test was video recorded 
from above.  Subjects were acclimated to the open field environment during three 
sessions beginning 13 days prior surgery. Baseline activity levels were collected five 
days prior to surgery. Open field activity was then assessed during Test Phase 1 and 2, 
on Days 10 and 21 post injury. 
Open field activity was scored post hoc from video analyses.  The number of 
squares crossed in the outer squares of the fields were operationalized as having two 
paws or more in the outside row of squares.  The number of squares crossed in the center 
(28 center squares), as well as time spent in the center squares were also recorded, and 
center field activity was computed in the following manner:  center squares crossed x 
center time. A decrease in the total number of squares crossed is interpreted as a sign of 
psychomotor retardation, while a decrease in center field activity is interpreted as a 
passive anxiety-like sign (Luedtke et al., 2014). 
Social exploration 
Social exploration was assessed in the same black plywood box used for open 
field activity. Subjects were placed into the center of the open field and allowed to 
explore for five minutes. A juvenile rat (<250 g weight), not exposed to any 
experimental treatment, was then placed into the open field as far from the experimental 
subject as possible. The experimental subject and the juvenile rat were filmed for 5 
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minutes. The test apparatus was disinfected with Nolvasan in between trials. Subjects 
were acclimated to the open field environment as described previously (see Open field 
activity). Baseline social exploration was assessed 5 days prior to surgery. Social 
exploration was assessed during Test Phase 1 and 2, on Days 10 and 21.  
Videos were scored post hoc, recording the total time the experimental subject 
spent interacting with the juvenile rat.  Interactions were operationalized as (1) pursuing 
the juvenile rat (while within three squares of the juvenile rat), and (2) sniffing any part 
of the juvenile rat’s body (Swain & Le, 1998). A total percent time spent in social 
exploration was obtained by computing the following: (social exploration behavior/300 
sec) x 100. Reduced social exploration behavior is a measure of loss of interest or 
pleasure (Luedtke et al., 2014). 
Learned helplessness 
The forced swim test was used to assess learned helplessness.  Subjects were 
allowed to acclimate in the testing room for ten minutes. The subject was then placed in 
a cylinder [15 (diameter) x 40 (height) cm] filled with water (23 ± 1˚C) from which they 
could not escape. The forced swim test is traditionally conducted using a 10-minute 
acclimation period and a 10-minute test period 24 hours later. However, Abel and 
Bilitzke (1990) found that immobility measured during a ten minute acclimation period 
was highly correlated with immobility measured in the test period conducted 24 hours 
later. Therefore, in the current study the subjects were filmed for a 10-minute test period 
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only (without the preceding acclimation to the water). The forced swim test was 
conducted during Test Phase 2, on Day 23 post injury. 
Time spent immobile was scored post hoc. Immobility was operationalized as the 
lack of movement except that required to keep the nose above water (Porsolt, Bertin, & 
Jalfre, 1977; Slattery & Cryan, 2012)- this included slight tail movement.  Immobility is 
interpreted as a symptom of learned helplessness, and characteristic of depression in 
rodent subjects (Luedtke et al., 2014). 
Food consumption 
Food was provided by laboratory members every day.  Food weight was recorded 
before and after injury, daily, at 9 AM.  Food consumption was calculated by subtracting 
the previous day’s food weight to the current day’s food weight. 
Anxiety  
The shock probe burying test was used to assess active anxiety. Rats were placed 
in a plastic box (56.51 cm L x 40.33 cm W x 33.35 cm H) with a small probe (5 cm) 
placed 2 cm above the bedding level at one far end of the box. The probe was built by 
wrapping two copper wires around a glass rod, and connecting the extremities to two 
dragon snaps.  The probe was connected to a source of mild electrical stimulation (0.08 
mA).  As soon as the subject came into contact with the probe (nose or forepaws touch), 
the electrical stimulation was turned off. The subjects were filmed for ten minutes.  The 
time that the rats spent engaged in burying and freezing behavior was recorded from post 
hoc video analyses.  The shock probe burying task was conducted during Test Phase 1 
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and 2, on Days 5 and 20 post injury.  The shock probe test was conducted on Day 20 
prior to the depression tests to ensure that behavioral testing stress itself would not affect 
the rats’ behavior in the test.  It must be noted that a baseline test of shock probe burying 
was not conducted. Performance on this test is sensitive to repeated testing as the rats are 
less likely to touch the probe after having experienced the electrical stimulation 
produced by the probe.  Studies indicate that rats can show retention of the learned 
aversion to the shock probe up to 20 days after the trial, especially if tested more than 
once before (De Boer & Koolhaas, 2003). Given the importance of obtaining behavioral 
data post SCI, and the learning effects of repeated testing, we decided to test subjects 
early in Test Phase 1, and then once more during Test Phase 2.  
The shock probe burying task is widely used as a measure of active anxiety, and 
has been validated by several groups (De Boer & Koolhaas, 2003; Poling, Cleary, & 
Monaghan, 1981; Treit, Pinel, & Fibiger, 1981). Greater time spent burying is 
interpreted as a sign of active anxiety. 
Assessment of pain reactivity 
Thermal reactivity 
The tail-flick test was used to assess thermal reactivity. Subjects were placed in 
clear restraining tubes and allowed to acclimate to the room and the tubes for ten 
minutes.  The testing room was maintained at 26.5˚C.  The subjects were then placed on 
the tail-flick apparatus, with their tail positioned in a 0.5 cm deep groove, cut into an 
aluminum block, and allowed to acclimate to the apparatus (IITC Inc., Life Science, CA) 
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for five minutes.  Thermal reactivity was then tested by applying the heat source (light) 
onto the rat's tail (3.8 cm from the tip of the tail).  Withdrawal latency from the light 
source was recorded. If a subject failed to respond, the test trial was automatically 
terminated after 8 s of heat exposure, to prevent tissue damage. Three tests occurred at 2-
minute intervals, and the last two test tail-flick latencies were recorded, and averaged.  
Baseline tail-flick scores were obtained 4 days prior to the surgery. The tail-flick test 
was subsequently conducted during Test Phase 1 and 2, on Days 11 and day 22 post 
injury.   
Mechanical reactivity 
The tactile test was used to assess mechanical reactivity.  Subjects were placed in 
clear restraining tubes and allowed to acclimate to the room and the tubes for 15 
minutes.  Mechanical reactivity was assessed using Von Frey filaments (Semmes-
Weinstein Anesthesiometer, Stoelting Co., Chicago, IL).  Von Frey filaments were 
applied every 2s in sequence to the plantar surface of the rats’ hindpaw (the L5 plantar 
dermatome, between the footpads).  The stimuli were presented until subjects exhibited a 
paw withdrawal/motor (spinal) and vocalization (supraspinal) response. The intensity of 
the stimuli that produced the responses was reported using the formula provided by 
Semmes-Weinstein: Intensity=log10 (10,000 * g force). If one or both responses were 
not observed, testing was terminated at an intensity of 6.65. Each subject was tested 
twice on each foot in a counterbalanced ABBA order. 
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In the girdle test, mechanical reactivity is assessed at the level of injury 
(Christensen & Hulsebosch, 1997).  The girdle zone for allodynic responding was drawn 
as a map grid on the rats with and indelible marker (44 squares).  A von Frey hair with 
bending force of 204.14 mN (26 g force) was applied to each point on this grid, and 
vocalization responses were recorded and mapped onto a grid map of that animal.  The 
von Frey stimulus was applied first to the left of the animal’s spinal column, in a rostral 
to caudal direction (11 squares per column, 2 columns), and then likewise to the right.  
The total number of vocalizations was recorded. 
Both the tactile and the girdle tests were conducted at baseline (five days prior to 
surgery), and during Test Phase 1 and 2, on Days 11 and day 22 post surgery. 
Assessment of recovery and general health 
Locomotor recovery 
The recovery of hindlimb stepping was scored using the Basso, Beattie and 
Bresnahan (BBB) scale (Basso, Beattie, & Bresnahan, 1995). This 21-point scale is used 
as an index of hindlimb functioning after a spinal injury. Using this scale, no movement 
of the hindlimbs (ankle, knee or hip) is designated a score of 0, and intermediate 
milestones include slight movement of one joint (1), extensive movement of all three 
joints (7), occasional weight supported stepping in the absence of coordination (10), and 
consistent weight supported stepping with consistent front limb- hind limb coordination 
(14). Higher scores reflect consistent limb co-ordination and improved fine motor skill.  
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The locomotor capacity (BBB) of subjects was observed for 5 minutes in an open 
field test area (99 cm diameter, 23 cm deep) and scored by a trained observer blind to the 
experimental groups on days 1-7, 9, 11, 13, 15, 18, and 21 post injury, from 9 am to 
noon. Care was taken to ensure that all observers’ scoring behavior had high intra- and 
inter-observer reliability (all r’s > 0.90). BBB scores were then transformed, as described 
in Ferguson et al. (2004), to help assure that the data were amendable to parametric 
analyses.   
Tissue collection 
Serum  
Twenty-four hours prior to blood collection, the rats’ hindlimbs were shaven 
with an electric trimmer to expose the saphenous vein.  The next day, topical lidocaine 
was applied to the shaven leg.  After waiting for six minutes (to give Lidocaine the time 
to act), each rat was inserted into a clean sock, with an opening for its nose, to breathe 
comfortably.  A compression point at the base of the leg was made to make the 
saphenous vein bulge out (similar to using a tourniquet). The vein was punctured using a 
20G needle and the blood was collected with a blood collection tube with a clot activator 
(MCB 16440 with Serum/Clotting activator, Braintree Scientific).  When enough blood 
had been collected, a clean compress was held on the puncture site to stop the bleeding.  
A 2.5 ml (s.c.) of saline was administered to the rats to prevent dehydration. Care was 
taken to perform this procedure in two minutes or less.  Blood was collected at baseline 
(2 days prior to surgery), on Day 1 post surgery, and during Test Phases 1 and 2, on 
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Days 10 and 24 post surgery, two hours prior to the beginning of the dark cycle.  
Saphenous veins punctured were alternated on each day of collection (i.e., left, right, 
left, right). 
The collected blood was left at room temperature for 30 minutes to allow 
clotting.  The samples were then centrifuged at 12 000 RPM for 15 minutes, at 4 °C. The 
top clear layer (serum) of each sample was extracted with a pipette and stored in a -20 
°C freezer.  
Fresh tissue collection 
Brain tissue 
Subjects were anesthetized with beuthanasia (.02 ml administered i.p.) and after 
verification of a deep level of anesthesia (absence of pedal and corneal reflex), an 
incision above the skull was made. The nasal bone and the cranial bone were cut to 
extract the brain. The brain was placed immediately on a glass dish on ice, and the 
hippocampi were extracted and flash frozen in liquid nitrogen, in less than 3 minutes 
(Spijker, 2011), for the subsequent extraction of total protein (detailed in the Chapter 
IV).  
Spinal cord tissue and thymus 
A 1 cm section of the spinal cord, centered over the injury site was removed and 
frozen in liquid nitrogen for the subsequent extraction of total protein (detailed in the 
Chapter IV).  In addition, the thymus was extracted and weighed as an index of 
psychological stress.  All tissue was collected on Day 25 post surgery.  
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Molecular analyses 
Alpha-2 ELISA 
Alpha-2 macroglobulin serum levels were assessed using an ELISA kit 
(ab157730; Abcam, Cambridge, MA; sensitivity 2.2277 ng/mL minimum calculated 
detectable dose) according to the manufacturer’s instructions.  Samples were read at 450 
nm using a microplate reader (Wallac Victor2 1420 Multilabel Counter, PerkinElmer, 
Waltham, MA). A 5-parameter logistic regression was used to derive the equation for the 
standard curve (optical density by alpha-2 macroglobulin ng/mL). The alpha-2 
macroglobulin level (ng/mL) for all samples was obtained by entering the mean optical 
density minus the Blank optical density in the equation for the standard curve, and 
solving for alpha-2 macroglobulin levels.  All alpha-2 macroglobulin levels were 
multiplied by the appropriate dilution factor.   
Cytokine/chemokine multiplex 
Serum and hippocampus homogenate levels of 27 cytokine/chemokines were 
assessed using a magnetic bead panel Milliplex MAP Kit (RECYMAG65K27PMX; 
EMD Millipore Corporation, Billerica, MA). The analytes assessed with this panel were 
G-SCF, Eotaxin, GM-CSF, IL-1α, Leptin, MIP-1α, IL-4, IL-1β, IL-2, IL-6, EGF, IL-13, 
IL-10, IL-12p70, IFN-γ, IL-5, IL-17A, IL-18, MCP-1, IP-10, GRO/KC/CINC-1, VEGF, 
Fractalkine, LIX, MIP-2, TNF-α, and RANTES.  Spinal cord homogenate levels of 20 
cytokine/chemokines were assessed using a magnetic bead panel Bio-Plex Pro Rat 
Cytokine 23-Plex Assay (L80-01V11S5; Bio-Rad Laboratories, Hercules, CA). This 
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panel assessed the same analytes as the Milliplex MAP Kit, except that Eotaxin, Leptin, 
MIP-1α, EGF, IP-10, Fractalkine, and MIP-2 were not included. Both kits followed the 
same basic protocols and used the same reagents.  All plates were read using a mini-
PROTEAN system (Bio-rad), and Bio-plex Array reader with High Throughput Fluidics 
system (Biorad). 
Experimental schedule 
The experimental timeline used for the injury severity (Chapter III) and group 
housing (Chapter IV) experiments is shown in Figure 1. Baseline measures for 
depression were collected in the week prior to injury. Following the contusion the tests 
were repeated on Days 10-11 and 20-21. The forced swim test was also conducted on the 
day immediately prior to injury and repeated on Day 23 post injury. As a measure of 
active anxiety, the shock probe test was conducted on Day 5 and 20 post injury.  
Recovery of locomotor function was assessed throughout the recovery period with tests 
of sensory function conducted on Day 11 and 22 post injury (see Figure 2). 
  
  
40 
 
    
  
F
ig
u
re
 2
 -
 E
x
p
er
im
e
n
ta
l 
sc
h
ed
u
le
. 
  
41 
 
Statistical analyses 
Identifying psychological well-being groups 
Principal components analysis 
The principal components analysis is a variable reduction technique that 
transforms a group of observations from a related set of variables into a (typically) 
smaller set of linear uncorrelated variables.  These uncorrelated variables are referred to 
as principal components. In both experiments (Injury Severity and Stress, and Group 
Housing), subjects’ scores on each of the behavioral measures (sucrose preference, 
forced swim, open field psychomotor activity, center field activity, social exploration, 
and shock probe burying) were averaged across Test Phase 1 and 2 and then subjected to 
a principal components analysis using orthogonal Varimax rotation.  The scores were 
averaged so that the equation derived in subsequent analyses would characterize 
behavioral signs that persisted into Test Phase 2 as well as have strong predictive value 
for Test Phase 1, or the early phase of SCI. Factors with loadings of ≥ 0.32 on more than 
one component (complex structure) were removed (Tabachnick & Fidell, 2007) and the 
analysis was repeated until no complex structure factors remained.  
Hierarchical cluster analysis 
Hierarchical cluster analysis is a statistical procedure used to separate a sample 
into clusters that the experimenter can operationally define.  In both the Injury Severity 
and Stress experiment, and the Group Housing experiment, a hierarchical cluster 
analysis was performed using the measures with moderate-strong loadings on the 
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components retained in the PCA. Specifically, average scores (derived from both Test 
Phase 1 and 2), on each of the retained behavioral tests, were first standardized by z 
scores.  Then a hierarchical cluster analysis was performed using Ward’s method and 
applying squared Euclidean distance as the distance measure.  The number of 
appropriate clusters based on the behavioral measures was obtained by looking for a 
break in the agglomeration coefficient change and by observing the dendrogram, which 
illustrates the distance between linked clusters.  It must be noted that the cluster sizes 
need not be even.  The cluster analysis was repeated using the same parameters but 
restricting it to a single solution of three clusters. A new variable, cluster membership, 
was generated for all subjects.  
The three clusters’ performance on all measures retained by the principal 
component analysis was compared across the recovery period (Test Phase 1 and 2) using 
repeated measure analyses of variance (ANOVAs).  Baseline scores were used as a 
covariate when significant (p<0.05).  Based on the pattern of behaviors exhibited by 
each cluster, the subject cohorts were labeled as exhibiting anxiety and depression like 
signs, depression like signs or as being healthy.   
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CHAPTER III 
CHARACTERIZING PSYCHOLOGICAL WELL-BEING AS A FUNCTION OF 
INJURY SEVERITY AT THE BEHAVIORAL LEVEL 
 
Introduction 
This experiment characterized depression and anxiety-like signs as a function of 
spinal cord injury (SCI) severity to determine whether post SCI inflammation 
contributes to decreased psychological well-being in a rodent model of SCI. Despite the 
high prevalence of depression and anxiety after SCI and their impact on the post-SCI 
experience, there has only been one empirical study of psychological well-being in an 
animal model of SCI (see Luedtke et al. 2014).  Luedtke et al. (2014) demonstrated that 
following SCI, approximately 35% of spinally contused rats show a depression-like 
profile.  This profile includes decreased psychomotor activity (open field test), decreased 
interest in social interactions (social exploration test), increased learned helplessness 
(forced swim test), and increased anhedonia (sucrose preference test).  Moreover, and 
critically for a SCI model of depression, Luedtke et al. (2014) provided solid evidence 
that the depression-like signs in these subjects were not simply due to reduced motor 
activity following SCI.  Indeed, there were no significant differences in terms of 
locomotor recovery of function and tissue sparing between depressed and non-depressed 
subjects.  This study also showed that some of the signs of depression could be reversed 
by SSRIs, but not all.  Specifically, learned helplessness on the forced swim test was 
reversed by administration of fluoxetine.  This further suggested that the depression-like 
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signs observed post SCI may not be due, at least not solely, to a serotonin imbalance.  
Instead, the paper proposed that inflammation may precipitate the development of 
depression after SCI. 
There is a growing body of literature pointing to a role of chronic peripheral and 
central inflammation in psychiatric illnesses such as major depressive disorders, anxiety, 
and even schizophrenia (Anisman, 2009; Black & Berman, 1999; Dantzer et al., 2008; 
Maes, 1999; Muller, 2013; Pace & Miller, 2009; Rosenblat et al., 2014; Uddin et al., 
2011; Wager & Gianaros, 2014; Walker et al., 2014; Zunszain et al., 2012).  For 
example, endotoxins can induce transient depressive-like symptoms in both humans and 
rats (De La Garza, 2005; Makino et al., 2000; Reichenberg et al., 2001) and 
immunotherapy can induce depression symptoms in cancer patients (Dantzer et al., 
2008).  Similarly, in a mouse model of premature aging, high levels of anxiety have been 
found to be associated with chronic inflammation (Vida et al., 2014).  Activation of the 
innate immune system particularly increases in brain IL-1β levels, increase anxiety-like 
behaviors at the open-field test and the elevated plus maze test (Chiu et al., 2014).  These 
findings highlight the association between inflammation and symptoms of depression 
and anxiety.   
SCI is characterized by inflammation and activation of the immune system. 
Following the injury, microglia, macrophages, and astrocytes are recruited to the site of 
trauma.  Pro-inflammatory cytokine genes and other inflammation-related genes are up-
regulated within hours of injury (Dumont et al., 2001; Yip & Malaspina, 2012), and 
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some for weeks following the injury (Jokic, Yip, Michael-Titus, Priestley, & Malaspina, 
2010; Malaspina, Jokic, Huang, & Priestley, 2008).  For example, in the hours following 
injury, the interleukin-6 gene (IL-6), the TNF gene, and the interleukin-1β gene (IL-1β) 
are up-regulated (Hayashi et al., 2000; Pan et al., 2002).  In addition, as spinal cord 
injury severity increases, pro-inflammatory cytokines are further up-regulated (Yang et 
al., 2005).  In a rodent study of SCI, inflammation post SCI was compared in mild and 
severe SCI subjects (10 g weight drop from 3 and 12 cm to T12, respectively).  
Immunocytochemical, RT-PCR and Western Blot assays on spinal cord tissue collected 
one to six hours post SCI indicated that IL-1β, IL-6 and TNF- production is increased 
in neurons and microglia of the spinal cord following SCI, and that this production is 
significantly greater following a severe injury rather than a mild injury (Yang et al., 
2005).  Therefore, immune system activation triggered by the SCI may influence 
psychological well-being, and may do so incrementally as injury severity increases.  
The current experiment aimed to extend our previous study (Luedtke et al. 2014) 
assessing behaviors not only characteristic of depression but also of anxiety in the rodent 
contusion model.  Further, given that inflammation at the level of the spinal cord is 
known to increase with severity of injury, we hypothesized that if inflammation at the 
level of the spinal cord directly results in decreased psychological well-being, the 
incidence of depression and anxiety should increase as a function of injury severity.   
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Methods 
Experimental design 
Subjects (N=47) received a mild, moderate, or severe contusion (see General 
Methods, Surgery, for detailed procedures) or were intact controls (n=12/group). For all 
subjects, psychological well-being was assessed at baseline with a comprehensive 
battery of tests as well as during Test Phase 1 (days 5 and 10) and 2 (days 20-21) post 
injury (See Figure 2). Intact subjects were tested at ages compatible with injured 
subjects.  The procedures for each of the tests are described in detail in the General 
Methods section (see Assessment of Psychological Well-being).  Food consumption was 
also collected daily, as an index of appetite deviation which is associated with 
depression in the clinical population.  
Locomotor function was assessed throughout the 21-day recovery period with the 
BBB scale (Basso et al., 1995), as described in the general methods.  Tests of sensory 
function (girdle, tactile and thermal reactivity), were also conducted during Test Phase 1 
(day 11) and Test Phase 2 (day 22).  Blood was collected in each test phase (pre-injury, 
days 2, 10, and 24).  Finally, at the end of the recovery assessment period, subjects 
received a lethal injection of beuthanasia (100 mg/kg, i.p.) and the injured spinal cord (1 
cm section centered on the lesion) and brain tissue (hippocampus) were collected.  
Thymus weight was also recorded as a physiological index of stress.  
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ELISAs 
Alpha-2 macroglobulin levels were assayed on Days 1, 10 and 24 with ELISAs 
on serum (Abcam 2013, kit ab157730).  Dilution tests were run to determine the 
appropriate dilution rate for all serum samples.  For intact subjects, the dilution rate was 
determined to be 300 x, whereas for all contused subject samples, the dilution rate was 
determined to be 3000 x.  Assays were run following the manufacturer’s protocol.  The 
best fit equation was determined to be a 5-parameter logistic regression.  The 
concentration readings were multiplied by the appropriate dilution factors (300 for intact 
subject samples, and 3000 for all contused subject samples). 
Statistical analyses 
We first used a series of statistical analyses to determine the psychological well-
being of the subjects in the experiment.  Detailed statistical steps are found in the 
General Methods chapter (Chapter 2).  First, a principal component analysis was used in 
order to determine which behavioral measures were correlated with each other.  This 
allowed us to select the behavioral measures providing the most informative and non-
repetitive information.  Next, we ran a hierarchical cluster analysis on the behavioral 
measures retained by the principal component analysis in order to identify the subject 
clusters in our sample.  The hierarchical cluster analysis identified subjects as exhibiting 
depression, anxiety/depression, or as being healthy.  After identifying the psychological 
well-being groups, we ran post-cluster repeated measure analyses of variance 
(ANOVAs) on the behavioral measures retained by the principal component analysis in 
order to confirm the hierarchical cluster group identifications.  Following confirmation 
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of the hierarchical cluster groups, we conducted one-way repeated measure ANOVAs on 
all test variables, to look for main effects of injury severity and psychological well-being 
on measures of depression, anxiety, pain, recovery of function and physiological 
markers. 
Results 
Principal component analyses: assessment of test validity for identifying 
psychological well-being  
The principal component analysis produced two components, which 
cumulatively explained 73.62% of the variance between subjects.  The first component 
contained the sucrose preference test and the shock probe burying test.  Open field 
activity and social exploration loaded on the second component (see Table 1).  Both 
components had Eigenvalues greater than 1, and explained a significant proportion of the 
variance between subjects. They were retained for subsequent analyses. 
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Behavioral test 
Components 
1 2 
Sucrose preference .178 .817 
Social exploration .872 -.150 
Open field activity .872 .214 
Shock probe burying .120 -.802 
 
Table 1 - Components of principal component analyses in Injury Severity experiment.  
Component loadings are shown for the behavioral tests retained.  To be retained, behavioral tests had to 
load with >.03 on one component only.  
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Hierarchical cluster analyses: classification of psychological well-being 
Average scores (derived from both Test Phases 1 and 2), for each of the 
behavioral tests retained in the principal component analysis (sucrose preference, shock 
probe burying, open field and social exploration), were used in the hierarchical cluster 
analysis.  The dendrogram produced by this analysis showed that subjects separated into 
three psychological well-being clusters, with 15 subjects in Hierarchical Cluster (HC) 
Group 1, 12 subjects in HC group 2, and 20 subjects in HC group 3 (see Figure 3). 
To identify the psychological well-being characteristics of each cluster group, the 
three groups were compared on each of the behavioral measures retained in the principal 
component analysis, across Test Phase 1 and 2.  Based on their performance on these 
measures, subjects in HC group 1 were labeled as exhibiting anxiety and depression like 
signs (or ANX/DEP), subjects in HC group 2 as exhibiting depression-like signs (or 
DEP) and subjects in HC group 3 as being healthy (or HEALTH).  Baseline differences 
were significant for the social exploration test and the open field activity test, 
[F(2,44)=5.82, p=.006 and F(2,44)=12.88, p=.000, respectively].  For these two 
variables, repeated measures analyses of covariances were conducted. It is important to 
note that including the baseline as a covariate does not correct fully for the differences 
pre-contusion on these two variables; however, it was not possible to counterbalance by 
psychological well-being pre contusion, since groups were determined post injury.  All 
post-hocs were conducted with multiple comparison Sidak tests.  
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Figure 3- Hierarchical cluster dendogram, Injury Severity and Stress experiment. The dendogram 
illustrates the results of the hierarchical cluster analysis, which separated the sample into three main 
clusters (Group 1 (n=15), Group 2 (n=12), Group 3 (n=20)), based on the subjects’ average performance 
on the behavioral tests retained by the principal component analyses.  The numbers on the y-axis represent 
the subjects.  
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Post hierarchical cluster comparisons 
Repeated measure ANOVAs revealed a main effect of psychological well-being 
(HC group) for the sucrose preference test [F(2,44)=8.39, p=.001], the open field activity 
test [F(2,43)=20.95, p=.000], the social exploration test [F(2,43)=7.67, p=.001], and the 
shock probe burying test [F(2,40)=41.32, p=.000].  For sucrose preference, subsequent 
ANOVAs (on Days 10 and 21 separately) confirmed that the HC groups differed at both 
time points [F(2,44)=8.67, p=.001, F(2,44)=3.89, p=.028, for Day 10 and 21 
respectively].  Post hoc analyses revealed that both on Day 10 and 21, the ANX/DEP 
group showed significantly lower sucrose preference than the HEALTH group, p= .05, 
Figure 4A and Figure 4B.  For open field activity, separate ANOVAs on Days 10 and 21 
also confirmed main effects of psychological well-being at both time points 
[F(2,43)=14.93, p=.000, F(2,43)=11.65, p=.000.]  Post-hoc analyses revealed that on 
Day 10, the DEP group showed decreased activity in an open field relative to the 
ANX/DEP and HEALTH group, ps < .05 (Figure 4C), and at Day 21, both the 
ANX/DEP and the DEP group showed decreased activity relative to the HEALTH 
group, ps ≤ .05, Figure 4D.  On the social exploration test, subsequent ANOVAs on 
Days 10 and 21 revealed that the HC groups also differed significantly on social 
exploration at Day 10, F(2,43)=14.27, p=.000.   
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Figure 4- Post hierarchical cluster differences.  The average (± standard error of the mean) 
performance of the ANX/DEP, DEP, and HEALTH group are shown on each task.  ANX/DEP subjects 
showed decreased sucrose preference relative to the HEALTH group on Days 10 and 21 (A and B), as 
well as increased shock probe burying relative to the DEP and HEALTH groups on Days 5 and 20 (G and 
H).  The DEP group showed decreased open field activity relative to the ANX/DEP and HEALTH group 
on Day 10 (C) and relative to the HEALTH group on Day 21 (D).  The DEP group also showed decreased 
social exploration on Day 10 (E) relative to the HEALTH group. * p <.05, # significant from all others.  
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Post-hoc analyses revealed that on Day 10, both the ANX/DEP and the DEP 
group showed significantly lower social exploration time than the HEALTH group, ps ≤ 
.05, Figure 4E.  Finally, on the shock probe burying test, separate ANOVAs on Days 5 
and 20 data confirmed that the HC groups differed significantly on shock probe burying 
at both time points [F(2,43)=28.66, p=.000, F(2,44)=11.12, p=.000.].  Post-hoc analyses 
revealed that the ANX/DEP group showed significantly higher percent time burying at 
the shock probe burying test than both the DEP and HEALTH groups, at both Days 5 
and 20, ps ≤ .05, Figure 4G and Figure 4H.  
Group membership 
As shown in Figure 5, examining group membership by psychological well-being 
and injury severity, we found that most intact subjects were classified as healthy, 
whereas most contused subjects were classified either as depressed or anxious/depressed.  
Although it did appear that the number of depressed subjects increased with injury 
severity and that the number of anxious/depressed subjects decreased with injury 
severity, there was no clear linear relationship overall with increased injury severity and 
number of subjects classified as either depressed or anxious/depressed.   
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Figure 5- Psychological well-being membership by injury severity.  This figure shows group 
membership by injury severity, and indicates the percentage of subjects identified as either 
anxious/depressed or depressed within each injury severity level.  
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Psychological well-being, pain, recovery of function and physiological markers 
following spinal cord injury 
First, to verify the effect of injury severity itself, one-way repeated measure 
ANOVAs were conducted by injury severity on all measures of depression- and anxiety-
like behavior, as well as pain, recovery of function, and physiological markers, followed 
by multiple comparison Sidak post-hocs tests to identify group differences on specific 
test days.  Then, to determine differences among psychological well-being groups on 
measures other than those retained by the principal component analyses and used for 
hierarchical clustering, one-way repeated measure ANOVAs were conducted by 
psychological well-being on measures of anxiety (center activity) and depression (forced 
swim) not used for hierarchical clustering, as well as on measures of pain, recovery of 
function, and physiological markers.  These comparisons across time were followed by 
one-way ANOVAs for each independent variable separately (injury severity and 
psychological well-being).  Subsequently, multiple comparison Sidak post-hocs tests 
were conducted to identify group differences on specific test days.  For each variable, 
the injury severity effect is reported first, followed by the psychological well-being 
effect.  Note that for sucrose preference, open field activity, social exploration, and 
shock probe burying, psychological well-being effects are not reported here, as these 
were already reported in the post-hierarchical cluster ANOVAs used to characterize the 
hierarchical cluster subgroups.  Finally, correlations were conducted to investigate 
associations between pain reactivity (tactile tests, tail-flick test, and girdle test) and 
behavioral measures (open field activity, social exploration, sucrose preference, forced 
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swim, shock probe burying, and center activity), as well as pain reactivity and peripheral 
inflammation (serum alpha-2 macroglobulin levels).  Correlations are reported only 
where found significant.  All graphs show psychological well-being groups 
(anxious/depressed, depressed, and healthy) subdivided by injury severity groups (intact, 
mild, moderate, and severe) for consistency. 
Depression measures 
While main effects of sucrose preference, open field activity, and social 
exploration were found by psychological well-being (Figure 6), as per the post 
hierarchical cluster repeated measure analyses run in the previous section, repeated 
measure ANOVAs found no main effect of injury severity on sucrose preference across 
time [F(3,43)=1.67, p=.188], open field activity across time, [F(3,42)=2.12, p=.112], 
social exploration across time [F(3,42)=1.55, p=.215], or forced swim on Day 24 
[F(3,41)=.175, p=.913].  Finally, repeated measure ANOVAs did not significant 
differences among psychological well-being groups on the forced swim test, 
F(2,42)=2.016, p=.146 (Figure 6G). 
  
  
58 
 
Figure 6- Depression measures by psychological well-being and injury severity.  The average (± 
standard error of the mean) performance of the ANX/DEP, DEP, and HEALTH group, separated by injury 
severity level, are shown on all depression measures.  No main effects of injury severity were observed.  
Main effects of psychological wellbeing were found.  The ANX/DEP group showed decreased sucrose 
preference relative to the HEALTH group (A and B). They also showed decreased open field activity and 
social exploration relative to the HEALTH group (C and D).  The DEP group showed decreased open field 
activity relative to the ANX/DEP (Day 10) and HEALTH group (Day 10 and 21), (C and D). The DEP 
group showed decreased social exploration relative to both the ANX/DEP and the HEALTH group on Day 
10 (E). No main effects of injury severity were found. *p <.05 
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Anxiety measures 
Shock probe burying.  While main effects of shock probe burying was found by 
psychological well-being (Figure 7), as per the post hierarchical cluster repeated 
measure analyses run in the previous section, repeated measure ANOVAs found no main 
effect of injury severity on shock probe burying across time, F(3,39)=1.37, p=.267. 
Center activity.  First, a repeated measures ANOVA revealed a main effect of injury 
severity for center activity in the open field, F(3,43)=3.27, p=.030.  Subsequent 
ANOVAs on Days 10 and 21 separately confirmed a main effect of injury severity on 
Day 21, F(3,43)=3.08, p=.037.  Post-hoc Sidak comparisons by injury severity indicated 
that on Day 21, the severe injury subjects showed a trend for greater center activity than 
the mild and moderate injury groups, p=.101 and .057 respectively, Figure 7D.  Second, 
a repeated measure ANOVA by psychological well-being revealed a main effect of 
psychological well-being for center activity, F(2,44)=4.19, p=.021.  Subsequent 
ANOVAs on Days 10 and 21 separately confirmed a main effect of injury severity on 
Day 21, F(2,43)=5.63, p=.007.  Post-hoc Sidak comparisons indicated that on Day 21, 
both the ANX/DEP and DEP groups showed reduced center activity relative to the 
HEALTH group, ps ≤ .05, Figure 7D.   
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Figure 7- Anxiety measures by psychological well-being and injury severity.  The average (± 
standard error of the mean) performance of the ANX/DEP, DEP, and HEALTH group, separated by injury 
severity level, are shown on all anxiety measures.  The severe injury group showed greater center activity 
than all other injury severity groups on Day 21 (D).  The ANX/DEP group showed increased shock probe 
burying  relative to the DEP and HEALTH groups on Days 5 and 20 (A and B).  On Day 21, the 
ANX/DEP and DEP groups showed decreased center activity relative to the HEALTH group (D).  * p 
<.05, # significant from all others. 
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Pain measures 
Tail-flick.  A repeated measures ANOVA revealed no main effect of injury severity nor 
psychological well-being, [F(3,43)=1.413, p=.252, F(2,44)=.676, p=.514, respectively.]. 
There were no baseline differences across groups. However, we did find a positive 
correlation between withdrawal latency at the tail-flick test on Day 11 and number of 
squares crossed in an open field on Day 10, r = .288, p < .049 . 
Tactile test- paw withdrawal threshold. First, a repeated measure ANOVA revealed a 
main effect of injury severity for the motor tactile test (paw withdrawal threshold), 
[F(3,43)=8.55, p=.000]. Post-hoc Sidak comparisons by injury severity confirmed that 
across the recovery period, the intact group showed a significantly higher paw 
withdrawal threshold than all other groups, ps ≤ .05.  Second, a repeated measure 
ANOVA revealed a trend for differences among psychological well-being groups for the 
motor tactile test (paw withdrawal threshold), [F(2,44)=2.758, p=.074].  Subsequent 
ANOVAs on Days 11 and 22 separately confirmed a main effect of psychological well-
being on Day 22, F(2,44)=3.451, p=.041.  Post-hoc Sidak comparisons by psychological 
well-being indicated that on Day 22, the ANX/DEP group showed a significantly lower 
paw withdrawal threshold than the HEALTH group, p < .05, Figure 8.   
Tactile test- vocalization threshold. First, a repeated measure ANOVA found no main 
effect of injury severity for the vocal tactile test (vocalization threshold), F(3,43)=.985, 
p=.409.  Second, a repeated measure ANOVA revealed a main effect of psychological 
well-being for the vocal tactile test, F(2,44)=8.75, p=.001.  Subsequent ANOVAs, 
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comparing vocalization thresholds on Days 11 and 22 separately, confirmed a main 
effect of psychological well-being on test Day 22, F(2,44)=7.024, p=.002, but not on 
Day 11.  Post-hoc Sidak comparisons by psychological well-being indicated that on Day 
22, the DEP group and the ANX/DEP group showed a lower vocalization threshold than 
the HEALTH group, ps < .05, Figure 8B.  Finally, vocalization thresholds on Day 22 
were negatively correlated with percent time spent burying on the shock probe burying 
test on Day 20, r = -.30, p < .04. 
Girdle test.  A repeated measures ANOVA revealed a main effect of injury severity for 
the girdle test, F(3,43)=2.957, p=.043.  Subsequent ANOVAs on Days 11 and 22 
separately confirmed a main effect of injury severity on Day 22, F(3,43)=2.892, p=.046.  
Post-hoc comparisons indicated that on Day 11, the intact group showed a trend towards 
a lower number of vocalizations at the girdle test than the severe group, p=.052.  Second, 
repeated measure ANOVAs did not find a main effect of psychological well-being for 
the girdle test, F(2,44)=.190, p=.828.  No differences were found at baseline either.  
However, the number of vocalizations on the girdle test on Day 11 were negatively 
correlated with sucrose preference on Day 10, r = -.322, p < .027.  
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Recovery measures 
Locomotor recovery of function.  First, a repeated measures ANOVA revealed a main 
effect of injury severity, F(3,35)=55.15, p=.000.  Post-hoc Sidak comparisons by injury 
severity confirmed that all four groups differed significantly from each other across time, 
ps ≤ .05, Figure 9.  Second, repeated measure ANOVAs found no main effect of 
psychological well-being, F(2,44)=.555, p=.578, Figure 10.  
Weight gain.  First, a repeated measures ANOVA revealed a main effect of injury 
severity on weight gain, F(3,35)=7.003, p=.001.  Post-hoc Sidak comparisons by injury 
severity confirmed that across time, the severe injury group gained significantly less 
weight post contusion injury than all the other groups, ps ≤ .05, Figure 11A and Figure 
11B.  Second, a repeated measure ANOVA found no main effect of psychological well-
being, F(2,44)=1.809, p=.176. 
Food consumption.  First, a repeated measures ANOVA revealed a main effects of injury 
severity on food consumption across time [F(3,43)= 3.92, p = .015].  Post-hoc Sidak 
comparisons found that the severe injury group showed significantly lower weight gain 
relative to the intact and moderate injury groups across time, ps ≤ .05.  Second, a 
repeated measure ANOVA did not find a main effect of psychological well-being on 
food consumption, F(2,44)= 2.161, p = .127.   
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Figure 10 - Locomotor recovery of function by psychological well-being.  The average (± 
standard error of the mean) performance of the ANX/DEP, DEP, and HEALTH groups are shown on the 
converted BBB test in the 21 days post injury.   Results with intact subjects included (A) and removed (B) 
are shown, for clarity.  No significant differences were found among the groups. 
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Figure 11- Weight gain by injury severity.  The average (± standard error of the mean) weight 
gain of the intact, mild, moderate and severe injury groups in the 21 days post injury are shown (A).  The 
severe injury group showed a significantly lower average weight gain than all other groups (B). * p <.05, # 
significant from all others. 
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Physiological measures 
Thymus. First, no main effect of injury was found.  Second, an ANOVA revealed a main 
effect of psychological well-being on thymus weight, with or without intact subjects 
included in the analysis [F(2,44)= 5.09, p = .010, F(2,33)= 5.161 p = .011,respectively].  
Post-hoc Sidak comparisons found that thymus weight was significantly decreased in the 
DEP group relative to the HEALTH group, p < .05, Figure 12.   
 
 
 
 
 
Figure 12- Thymus weight by psychological well-being and injury severity.  The average (± 
standard error of the mean) thymus weights are shown by psychological well-being and injury severity 
groups.  No main effect of injury severity was found.  The DEP group showed decreased thymus weight 
relative to the HEALTH group, * p < .05. 
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Alpha-2 macroglobulin.  It was expected that levels of alpha-2 macroglobulin would be 
extremely low in intact subjects.  Therefore, they were excluded from analyses, and 
instead, all alpha-2 macroglobulin levels were normalized to intact animals by dividing 
each data point for a given day of collection by the intact subjects’ average level of 
alpha-2 macroglobulin for that same day.  Furthermore, because alpha-2 macroglobulin 
is an acute phase protein, we expected group differences to be evident shortly after the 
spinal cord injury only.  Therefore, we conducted ANOVAs on days 1, 10 and 24 
separately.  First, we found no main effect of injury severity for alpha-2 macroglobulin 
on any day.  Second, we found a trend towards a main effect of psychological well-being 
at Day 1 post injury only, F(2,31)= 3.007, p = .064.  Post-hoc analyses revealed a trend 
for both the ANX/DEP and DEP groups to show increased levels of serum alpha-2 
macroglobulin on Day 1 relative to the HEALTH group (normalized to intact animals), p 
= .16 and .09 respectively, Figure 13A and Figure 13B.  
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Discussion 
These data support the hypothesis that the inflammation due to SCI decreases 
psychological well-being.  Using principal components and cluster analyses, based on 
behavioral measures of depression and anxiety, we determined that 25.5% of rodents 
exhibited a depression-like profile (30.5% of contused subjects), consistent with results 
of an earlier depression study (Luedtke et al., 2014). Another 31.9% of rodents exhibited 
an anxiety- and depression-like profile (33.3% of contused subjects).  This is a novel 
assessment of psychological well-being in the rodent SCI model. Subjects were 
identified as exhibiting an anxiety-like profile based on performance on an active 
anxiety test, the shock probe burying task, and the categorization was confirmed by 
group differences on a passive anxiety test, center time and activity in the open field 
task.  Depressed subjects showed psychomotor reduction (decreased squares crossed in 
an open field), decreased interest in social interactions, and passive anxiety (reduced 
center activity in an open field).  Anxious/depressed subjects in turn showed anhedonia 
(decreased sucrose preference), psychomotor reduction, decreased interest in social 
interactions, and clear active and passive anxiety (shock probe burying and center 
activity in an open field, respectively).  Notably, behavioral signs of depression and 
anxiety persisted in both the acute and chronic phases of injury, long after sickness 
behavior would have resolved. 
We observed a large proportion of subjects with a “non-healthy” profile (either 
falling into the depressed or anxious/depressed categories).  In Luedtke et al. (2014), 
34.6% of subjects showed a “non-healthy” profile, which was formed by the depressed 
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cluster (9 subjects out of 26).  Conversely, in the present study of 47 subjects, 57.4% of 
subjects showed a non-healthy profile, which comprised both a depressed cluster (n=12), 
and an anxious/depressed cluster (n=15).  This increased proportion of non-healthy 
subjects may be attributed to the rise of an anxiety-like profile.  Indeed, if we exclude 
the anxious/depressed cluster, and only consider the depressed cluster versus the healthy 
cluster, as was done in Luedtke et al. (2014), we find that 37.5% of subjects showed a 
“non-healthy” profile, a figure similar to that of Luedtke et al. (2014).  The increase in 
anxiety-like signs in this experiment could be explained by one important difference 
between the two studies.  In Luedtke et al. (2014), no blood draws were performed, 
whereas in the present experiment, blood draws were performed prior to the contusion 
injury, and on days 1, 10 and 24 post injury.  We suspect that the repeated blood draws, 
in combination with the invasive contusion surgery, may have acted as a stressor to 
increase anxiety-like behavior.  However, these blood draws were necessary in this 
study, to assess peripheral inflammation across days post SCI. 
At a physiological level, the depression-like profile and the anxiety/depression 
like profile were both associated with increased expression of an acute phase protein, 
alpha-2 macroglobulin, which is commonly used as an index of peripheral inflammation 
in the rat. It is also known that thymus weight decreases with depression (Leonard & 
Song, 1996; Song & Leonard, 2000).  Consistent with this, we also found that at time of 
sacrifice, the thymus weight of depressed subjects was significantly smaller than that of 
the healthy subjects.  Elevated serum levels of pro-inflammatory cytokines have been 
found in patients with chronic SCI (Davies et al., 2007; Hayes et al., 2002), as well as in 
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animal models of SCI (Hasturk et al., 2009).  As expected, spinally contused subject 
overall exhibited increased peripheral inflammation relative to intact subjects.   
Given that spinal cord inflammation is known to increase with severity of injury 
in the acute phase of injury, we initially expected psychological well-being to decrease 
as a function of injury severity.  However, there were no significant differences in alpha-
2 macroglobulin levels between the mild, moderate, and severe injury groups, and 
psychological well-being also did not decrease as a function of injury severity.  Indeed, 
on most behavioral tasks (sucrose preference, open field activity, social exploration, 
forced swim, and shock probe burying), there was no main effect of injury severity.  A 
main effect of injury severity was only observed for activity in the center of an open 
field.  However, it was the severe injury group that displayed the least anxiety-like 
behavior (i.e., greater center activity on Day 21 post injury (see Figure 7).  These results, 
in addition to the fact that we found no differences in locomotor recovery of function 
between psychological well-being groups, support the initial findings of Luedtke et al. 
(2014), demonstrating that symptoms of depression and anxiety in the rodent model of 
SCI cannot be attributed simply to reduced motor function affecting performance in the 
behavioral tasks used to assess psychological well-being.  
The effects of pain are more difficult to ascertain.  We found that the 
anxious/depressed group showed a lower paw withdrawal threshold than the healthy 
group on the tactile test, and that both the anxious/depressed and the depressed group 
showed a lower threshold for vocalization than the healthy group at the tactile test.  
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Although we found some correlations between pain reactivity (tail-flick test, girdle test, 
and tactile vocal) and performance on certain behavioral tasks to assess depression- or 
anxiety-like behavior (open field activity, sucrose preference, and shock probe burying, 
respectively), these were not systematic.  They appeared on one day only (tail-flick and 
girdle on Day 11, tactile on Day 22), and affected only one behavioral measure each.  It 
is possible that increased pain sensitivity reduces motivation to perform in the behavioral 
tasks, therefore leading to apparent depression-like behavior that in reality is simply 
reduced motivation.  However, our experimental design does not allow us to 
systematically address this concern.  We can only surmise that the lack of a generalized 
effect across tasks refutes this explanation.  An experiment in which non-steroidal anti-
inflammatory drugs are administered before behavioral testing would be useful to 
answer this question in the future.  Based on our results, we suggest that decreased pain 
thresholds and decreased psychological well-being may share a common underlying 
factor- inflammation. Rather than pain or decreased motor function producing behavior 
that resembles depression, we propose that inflammation is the proximate cause of 
decreased psychological wellbeing (and pain) after SCI. 
This experiment is the first SCI study to examine in combination, psychological 
well-being, pain reactivity, and inflammation following a spinal cord contusion injury in 
a rodent model.  We provide a first set of evidence indicating that following a spinal 
cord contusion injury, a subgroup of rats exhibit depression- and anxiety-like signs, 
which are accompanied by increased peripheral inflammation and decreased pain 
thresholds.  These results support the hypothesis that SCI impacts the immune system 
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which then contributes to decreased psychological well-being following SCI.  In the next 
chapter we assess a tableau of cytokine and chemokine expression peripherally (serum) 
and centrally (brain and spinal cord) post SCI, and investigate how they might be 
associated with depression.  A better understanding of the role of SCI-triggered 
inflammation in decreased psychological well-being at a molecular level could 
eventually lead to better targeted treatments for people with SCI suffering from 
depression.  
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CHAPTER IV 
 MOLECULAR CHANGES ASSOCIATED WITH PSYCHOLOGICAL WELL-
BEING FOLLOWING SPINAL CORD INJURY 
 
Introduction 
This experiment aimed to investigate the relationship between inflammation post 
spinal cord injury (SCI) and psychological well-being, as well as pain reactivity.  In 
Chapter III, we found that a subgroup of spinally contused rodents exhibited depression- 
and anxiety-like signs post SCI, as well as increased serum alpha-2 macroglobulin levels 
relative to subjects with a healthy psychological well-being.  Our results are in line with 
a growing literature suggesting that at least sub-types of mood disorders are 
characterized by increased activation of the immune system (Smith, 1991; Maes, 1999).   
According to the cytokine hypothesis, pro-inflammatory cytokines can be 
directly involved in inducing depression.  Cytokines such as IL-6 and TNF-α can assist 
in the breakdown of 5-serotonin into 5-hydroxyindoleacetic acid (5-HIAA).  In addition, 
pro-inflammatory cytokines can increase the activity of indolamine 2,3-dioxygenase 
(IDO) (Maes et al., 2011), which catalyses the conversion of tryptophan, the precursor 
for serotonin, into kynurenine.  As a result, levels of tryptophan available to produce 
serotonin are reduced (Capuron et al., 2003; Capuron et al., 2001).  Cytokines can also 
alter the synthesis of catecholamines by triggering the synthesis of precursors for 
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dopamine, norepinephrine and epinephrine (Sperner-Unterweger et al., 2014).  These 
mechanisms are thought to contribute to a cytokine-mediated form of depression.  
It is well known that in the hours and weeks following SCI, pro-inflammatory 
cytokine genes and other inflammation-related genes are up-regulated in the spinal cord 
(Dumont et al., 2001; Jokic et al., 2010; Malaspina et al., 2008; Yip & Malaspina, 2012).  
In addition, increased serum levels of pro-inflammatory cytokines have been observed in 
patients with chronic SCI (Davies et al., 2007; Hayes et al., 2002), as well as in animal 
models of SCI (Hasturk et al., 2009).  Given the psychoneuroimmunological evidence 
suggesting an association between immune activation and depression, it is possible that 
increases in pro-inflammatory cytokines following SCI contribute to decreased 
psychological well-being.   
To the best of our knowledge, changes in brain cytokines post SCI have not been 
studied.  However, we know that the blood-brain barrier is ruptured as a result of SCI.  
We also know that peripheral cytokines can reach the central nervous system via various 
routes, such as active transport, leaky sites, macrophage activation, or through the blood 
(Roman et al., 2013).  Furthermore, there are some indications that peripheral cytokine 
levels are altered post SCI.  Therefore, it is possible that changes in cytokines expression 
at the level of the spinal cord following injury impact peripheral and supraspinal levels 
of cytokines, and subsequently play a role in decreased psychological well-being post 
SCI.  
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In this study, we hypothesized that the increased incidence of depression and 
anxiety-like signs observed in contused subjects in Chapter III would be associated with 
increased peripheral and central levels of pro-inflammatory cytokines.  Building on data 
collected in Chapter III, in the present chapter, we used Multiplex assays to identify 
changes in cytokine and chemokine levels both peripherally (serum) and centrally (brain 
and spinal cord). 
Methods 
The tissue collected from the subjects in the Injury Severity and Stress 
experiment (Chapter III) was analyzed.  This included serum, hippocampi and spinal 
cords from subjects in the mild, moderate, or severe contusion (see General Methods, 
Surgery, for detailed procedures) conditions or in the intact control condition 
(n=12/group), at time points corresponding to baseline and days 1, 10 and 24 (serum) or 
25 (hippocampi and spinal cord) post contusion injury.  The hippocampi were chosen for 
these brain analyses because pre-clinical and clinical studies of depression consistently 
find that depressed subjects show decreased hippocampal volume (Duman et al., 1999; 
MacQueen et al., 2003; Paradise et al., 2012), increased microglial density (Stockmeier 
et al., 2004) and increased glucocorticoid levels (Bremner et al., 2000).   
Protein extraction 
The lysis buffer was made as described in Bake, Selvamani, Cherry, & Sohrabji, 
2014 and Jezierski & Sohrabji, 2001:  0.5M Tris (pH 7.4), 5M NaCL, 50% glycerol to 
stabilize protein, 100mM EGTA (pH 8) to inhibit metalloproteases and cysteine 
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proteases, 10mM Na-orthovanadate (pH 10) as a phosphatase inhibitor, 1mM ZnCl2 as a 
phosphatase inhibitor, 0.5M NaF as a phosphatase inhibitor, reconstituted aprotinin as a 
phosphatase inhibitor, reconstituted leupeptin to inhibit serine and cysteine proteases, 
10% triton X-100 to solubilize membranes and 200mM PMSF with DMSO added at the 
time of extraction to inhibit serine proteases. 
The lysate was obtained by homogenizing the hippocampi and spinal cord in 600 
µL lysis buffer with a pestle on ice.  The samples were next centrifuged at 18 000 rpm 
for 30 minutes at 4 °C, and the supernatant was collected and stored at -20 °C.   
Total protein  
A BCA Protein Assay Kit was used to assay the total protein concentration in 
hippocampal and spinal cord supernatant (Pierce, Rockford, IL).   Standards from 0 to 
200 were made from the Albumin provided in the kit and MQ water (See Table 2).  
Samples were prepared by mixing 5 µL of tissue (spinal and hippocampal) 
homogenate in lysis buffer and 45 µL of MQ water in 1.7 mL plastic tubes.  The protein 
assay reagent was prepared in a 50:1 ratio for A:B, and 1mL was added to all standards 
and all prepared samples.  All tubes (standards and samples) were incubated in a water 
bath for one hour at 37 °C.  Then, 200 µL of each standard and sample were loaded in 
duplicate onto a 96-well microplate.  Absorbance was measured at 562nm on a 
spectrophotometer (Biomate 3, Thermo Electron Corporation, Waltham, MA).  
Concentrations were obtained in µg protein/ µL. 
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Standards (µg/mL) Albumin (µL) MQ Water (µL) 
0 0 50 
5 1.25 48.75 
10 2.5 47.5 
15 3.75 46.25 
20 5 45 
25 6.25 43.75 
30 7.5 42.5 
35 8.75 41.25 
40 10 40 
60 15 35 
80 20 30 
100 25 25 
150 37.5 12.5 
200 50 0 
 
Table 2- Preparing standard curve (albumin).  
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Multiplex 
Serum and hippocampal levels of 27 cytokine/chemokines were assessed on 
Days 1 and 25 using a magnetic bead panel Milliplex MAP Kit (Milliplex MAP kit, 
RECYTMAG-65k).  The cytokines and chemokines assessed are listed in Table 3, Table 
4 and Table 5  Although we recognize the limitations in identifying cytokines and 
chemokines as either pro- or anti-inflammatory given the complex dual roles of most, we 
have organized the analytes according to their most general roles in inflammation.  
Therefore, Table 3 displays the “pro-inflammatory” cytokines and chemokines, and 
Table 4 lists the “anti-inflammatory” cytokines and chemokines.  Finally, we have added 
Table 5 to list the cytokines and chemokines for which there is not a clear pro versus 
anti-inflammatory role defined. 
Spinal cord homogenate levels of 20 cytokine/chemokines were assessed using a 
magnetic bead panel Bio-Plex Pro Rat Cytokine 23-Plex Assay (L80-01V11S5; Bio-Rad 
Laboratories, Hercules, CA).  This panel assessed the same analytes as the Milliplex 
MAP Kit, except that Eotaxin, Leptin, MIP-1α, EGF, IP-10, Fractalkine, and MIP-2 
were not included.  Both kits followed used the same reagents and followed equivalent 
protocols.   
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Analyte Function References 
Eotaxin  
Activator and chemoattractor. 
Also referred to as CCL11. 
(Menzies-Gow et al., 
2002) 
GM-CSF 
(Granulocyte-
macrophage colony-
stimulating factor) 
Stimulates stem cells granulocyte 
production (neutrophils, 
eosinophils, and basophils) and 
monocytes. 
(Shi et al., 2006) 
Il-1α  
(interleukin-1α) 
Activates a set of immune system 
response processes shortly after 
infection. 
(Dinarello, 2009) 
MIP1-α 
(Macrophage 
inflammatory protein-
1α) 
Involved in recruiting and 
activating leukocytes. 
(Cook, 1996) 
IL-1β  
(interleukin-1β) 
Activates microglia and immune 
cells (cytokines) 
(Audet & Anisman, 
2013) 
IL-2  
(interleukin-2) 
Involved in the differentiation of T 
cells. 
(Audet & Anisman, 
2013) 
IL-6  
(interleukin-6) 
Stimulates immune response. 
(Audet & Anisman, 
2013) 
IL-12p70  
(IL-12 phosphorylated 
70 kDa) 
Involved in differentiating T cells 
to Th1 cells. Stimulates production 
of TNF- α and IFN-γ. 
(Muller-Berghaus et 
al., 2004) 
IFN-γ  
(interferon- γ) 
Activates microglia, natural killer 
cells and macrophages 
(Audet & Anisman, 
2013) 
IL-5  
(interleukin-5) 
Stimulates B cell growth.  
Involved in eosinophil activation. 
(Kouro & Takatsu, 
2009) 
IL-17a  
(interleukin-17a) 
Involved in delayed-type 
reactions.  Increases chemokine 
production for the recruitment of 
monocytes and neutrophils to 
inflammation site. 
(Jin & Dong, 2013) 
IL-18  
(interleukin-18) 
Stimulates T cell and natural killer 
cell maturation, and stimulates 
IFN-γ production. 
(Audet & Anisman, 
2013) 
 
 
Table 3- Pro-inflammatory cytokines and chemokines assessed with Multiplex assay. 
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Analyte Function References 
MCP-1  
(monocyte chemotactic 
protein-1) 
Recruits monocytes, memory T 
cells and dendritic cells to 
inflammation site.  Also referred 
to as chemokine C-C motif ligand 
2 (CCL2). 
(Deshmane, 
Kremlev, Amini, & 
Sawaya, 2009) 
IP-10  
(interferon gamma-
induced protein 10) 
Chemoattractant for activated T 
cells. Involved in recruiting T cells 
to sites of inflammation. Also 
referred to as C-X-C motif 
chemokine 10 (CXCL10). 
(Dufour et al., 
2002) 
GRO-KC  
(growth-related 
oncogene/keratinocyte 
derived chemokine) 
Chemoattractant for neutrophils. 
Also referred to as CXCL1. 
(Roy, Richard, 
Dumas, & 
Vallieres, 2012) 
VEGF  
(Vascular endothelial 
growth factor) 
Critical in angiogenesis.   Can 
increase IFN-γ and decrease IL-10 
in T-cells, therefore increasing 
pro-inflammatory T-cell 
differentiation. 
(Mor, Quintana, & 
Cohen, 2004) 
LIX 
(lipopolysaccharide-
induced CXC 
chemokine) 
Involved in cell migration and 
activation of neutrophils. Also 
referred to as CXCL5. 
(Choong, Yong, 
Tan, Luo, & 
Lodish, 2004) 
MIP-2  
(macrophage 
inflammatory protein 
2) 
Chemoattractant for neutrophils. 
Also referred to as CXCL2. 
(Driscoll, 1994) 
TNF-α  
(Tumor necrosis factor- 
α) 
Activates microglia and immune 
cells. 
 
(Audet & Anisman, 
2013) 
RANTES  
(regulated on 
activation, normal T 
cell expressed and 
secreted) 
Chemoattractant for T cells, 
eosinophils, and basophils. Also 
referred to as Chemokine (C-C 
motif) ligand 5 (CCL5). 
(Kapp, Zeck-Kapp, 
Czech, & Schopf, 
1994) 
 
Table 3- Continued. 
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Analyte Function References 
IL-4  
(interleukin IL-4) 
Involved in a shift from Th1 to Th2. 
Decreases production of 
macrophages, IFN-gamma, and 
dendritic cell IL-12. 
(Audet & 
Anisman, 2013) 
EGF  
(epidermal growth 
factor) 
Stimulates cell growth, proliferation 
and differentiation. 
(Menard et al., 
2012) 
IL-13  
(interleukin IL-13) 
Inhibits cytokine production by B 
cells and monocytes. Induces 
protein-degrading enzyme matric 
metalloproteinases (MPPs). 
(Wynn, 2003) 
IL-10  
(interleukin IL-10) 
Involved in shift from Th1 to Th2.  
Reduces immune response 
activation. 
(Audet & 
Anisman, 2013) 
 
Table 4- Anti-inflammatory cytokines and chemokines assessed with Multiplex assay. 
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Analyte Function References 
G-CSF  
(Granulocyte colony-
stimulating factor) 
Neurogenesis, neuroplasticity. 
Counters apoptosis. Can have both 
pro- and anti-inflammatory effects. 
(Boneberg & 
Hartung, 2002; 
Lawlor et al., 2004) 
Leptin 
Marker of inflammation. Regulates 
energy consumption.  Related to 
appetite and hunger, metabolism, 
and behavior. 
(Fantuzzi & 
Faggioni, 2000) 
Fractalkine 
Anti-apoptotic. Involved in 
chemotaxis and leukocyte adhesion, 
as well as the survival of various 
cells during inflammation. Also 
referred to as CX3CL1. 
(White & Greaves, 
2012) 
 
Table 5- Unclassified cytokines and chemokines assessed with Multiplex assay. 
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The assays were run according to the manufacturer’s instructions, including for 
dilution recommendation.  In summary, a 96-well microplate was first coated with 200 
µL assay buffer/well.  The plate was left on a plate shaker for 10 minutes at room 
temperature, and the contents were decanted.  Next, 25 µL of standards and controls 
were added to the appropriate wells (in duplicates), and 25 µL of assay buffer was added 
to the background wells and the sample wells.  Following this, 25 µL of appropriate 
matrix solution was added to the background, standards, and control wells.  For serum 
samples, the serum matrix provided with the kit was used as matrix.  For the tissue 
supernatant, lysis buffer (with necessary PMSF) was used as matrix.  Next, 25 µL of 
samples was added to the sample wells.  Serum samples were diluted 1:2 in assay buffer, 
whereas tissue supernatant was not diluted.  Then, the premixed beads were sonicated 
thoroughly and 25 µL of the mixed beads were added to all wells in the dark, after which 
the plate was sealed, wrapped in foil, and incubated at room temperature (20 to 25 ˚C) 
for two hours on a plate shaker.  Next, the wells were decanted and washed two times 
using a hand-held magnet, 25 µL of detection antibodies was added to each well, and the 
plate was sealed, wrapped in foil, and incubated for one hour at room temperature on a 
plate shaker.  After this second incubation, 25 µL of Streptavidin-Phycoerythrin was 
added to each well, and the plate was incubated as described above for 30 minutes.  
Finally, wells were decanted, washed twice, and 125 µL of Sheath Fluid was added to all 
wells.  The beads were resuspended for five minutes on a plate shaker before running the 
plate using a Bio-Plex suspension array system (Bio-Rad Laboratories, CA) which was 
calibrated on the day of use according to the manufacturer’s instructions.  The program 
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was set for 100 µL/well, 50 beads per bead set.  The median fluorescent intensity of all 
27 analytes was obtained for all standards and samples, and analyte concentration in 
samples (in pg/mL) was calculated by deriving a 5-parameter logistic standard curve for 
each analyte separately.   
For serum samples, the calculated concentration for all analytes was multiplied 
by the dilution factor 2.  For protein supernatant samples, the calculated concentration 
for all analytes was normalized to the total protein content, obtained from the BCA 
Protein Assay.  
Results 
The results are reported for serum, hippocampi, and spinal cord separately.  First, 
4 (injury severity groups) x 3 (hierarchical cluster groups) ANOVAs were conducted on 
Day 1 and Day 24 (for serum) and Day 25 (for tissue) data separately, to identify main 
effects of injury severity and psychological well-being as well as interaction effects.  If 
main effects of injury severity were ruled out in the 4 x 3 ANOVAs, one-way ANOVAs 
were conducted to examine the effects of psychological well-being specifically.  For 
spinal cord tissue, however, one-way ANOVAs were also conducted by injury severity 
groups alone, since differences by injury severity were expected in the spinal cord based 
on our hypothesis. 
Serum  
We assessed the levels of 27 cytokine/chemokines in serum on Day 1 and Day 24 
post SCI.  Day 10 levels could not be assessed for technical reasons beyond our control, 
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which resulted in the loss of those samples.  On Day 1 post SCI, 4 x 3 ANOVAs ruled 
out a main effect of injury severity for all the analytes except MCP-1, for which a main 
effect of injury severity was observed [F(3,19)=5.65, p=.006].  Post-hoc Sidak 
comparisons indicated that the intact group exhibited a significantly lower level of MCP-
1 than the moderate and severe injury groups, ps ≤ .05.  For all other analytes, one-way 
ANOVAs by psychological well-being were conducted, and these were followed by 
post-hoc Sidak comparisons. 
One-way ANOVAs revealed a main effect of psychological well-being for GM-
CSF [F(2,27)=11.923, p=.000], GRO-KC [F(2,27)=5.832, p=.008], MIP-2 
[F(2,27)=5.66, p=.009], TNFα [F(2,27)=4.889, p=.015], IL-1β [F(2,27)=2.727, p=.083], 
IL-10 [F(2,27)=4.098, p=.028], Fractalkine [F(2,27)=3.537, p=.043], and LIX 
[F(2,27)=3.731, p=.037]. Post-hoc Sidak comparisons revealed that the depressed and 
anxious/depressed groups showed higher levels of GM-CSF than the healthy group, ps ≤ 
.05.  Furthermore, the depressed group exhibited levels of GRO-KC and MIP-2 that 
were higher than those of the healthy group, ps ≤ .05. The levels of TNF-α, IL-1β and 
Fractalkine in the depressed group also showed a trend towards levels higher than those 
of the healthy group, (p=.054, p=.093 and p=.06, respectively). Moreover, the depressed 
group showed levels of TNF-α and LIX that were higher than those of the 
anxious/depressed group, ps ≤ .05.  Furthermore, IL-10 and Fractalkine in the depressed 
group also showed a trend towards levels greater than those of the anxious/depressed 
group, (p=.07 and p=.08, respectively).  Finally, the depressed group showed higher 
levels of IL-10 than the healthy group (p<.05) and a trend towards greater levels of 
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Fractalkine than the healthy group (p=.06).  The Day 1 differences in pro-inflammatory 
cytokines by psychological well-being are shown in Figure 14, and anti-inflammatory 
and unclassified cytokines in Figure 15.  Figure 16 shows the significant differences that 
still hold when the intact subjects are removed from analyses.  Non-significant results 
obtained by injury severity for Day 1 serum are reported in Figure 17 and Figure 18.  
On Day 24 post SCI, 4 x 3 ANOVAs ruled out a main effect of injury severity 
for all the analytes.  One-way ANOVAs revealed a main effect of psychological well-
being for GM-CSF [F(2,33)=5.372, p=.010], IL-1β [F(2,33)=4.561, p=.018], Rantes 
[F(2,33)=4.042, p=.027], and IL-17A [F(2,32)=3.321, p=.049].  Post-hoc Sidak 
comparisons revealed that the depressed group showed higher levels of GM-CSF and IL-
1β than the anxious/depressed and the healthy group, ps ≤ .05, Figure 19A.  
Furthermore, both the depressed group and the anxious/depressed group showed lower 
levels of Rantes than the healthy group, ps ≤ .05, Figure 19B.  Finally, the 
anxious/depressed group showed lower levels of IL-17A than the healthy group, p<.05, 
Figure 19B. Although no significant differences were found in anti-inflammatory 
cytokines, a trend is observed for IL-13, with the depressed group showing increased 
levels relative to both the anxious/depressed and the healthy group (Figure 20).  Figure 
21 shows the significant differences that still hold when intact subjects are removed from 
analyses.  Finally, non-significant results obtained by injury severity on Day 24 serum 
are reported in Figure 22 and Figure 23. 
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Figure 15- Day 1 serum anti-inflammatory and unclassified analytes by psychological well-being.  
The average (± standard error of the mean) concentration of anti-inflammatory (A) and unclassified (B) 
cytokines and chemokines in serum are shown for the ANX/DEP, DEP and HEALTH groups.  IL-13 and 
G-CSF median fluorescent intensities were out of range for all subjects; therefore, pg/mL concentrations 
were not obtained. * p <.05.   
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Figure 18- Day 1 serum anti-inflammatory and unclassified analytes by injury severity.  The 
average (± standard error of the mean) concentration of anti-inflammatory (A) and unclassified (B) 
cytokines and chemokines in serum are shown for the intact, mild, moderate and severe injury groups.  IL-
13 and G-CSF median fluorescent intensities were out of range for all subjects; therefore, pg/mL 
concentrations were not obtained. 
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Figure 20- Day 24 serum anti-inflammatory and unclassified analytes by psychological well-
being.  The average (± standard error of the mean) concentration of anti-inflammatory (A) and unclassified 
(B) cytokines and chemokines in serum are shown for the ANX/DEP, DEP and HEALTH groups.  
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Figure 23 - Day 24 serum anti-inflammatory and unclassified analytes by injury severity. The 
average (± standard error of the mean) concentrations of anti-inflammatory (A) and unclassified (B) 
cytokines and chemokines in serum are shown for the intact, mild, moderate and severe injury groups.  
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Hippocampus 
We assessed the levels of 27 cytokine/chemokines in the hippocampi protein 
supernatant (left and right combined). 4 x 3 ANOVAs ruled out a main effect of injury 
severity for all the analytes.  One-way ANOVAs revealed a main effect of psychological 
well-being for two pro-inflammatory cytokines, Il-1α [F(2,32)=4.463, p=.020] and TNF-
α [F(2,32)=3.537, p=.041].  
Post-hoc Sidak comparisons revealed that the anxious/depressed group showed 
higher levels of Il-1α and TNF-α than the healthy group, ps ≤ .05, Figure 24A. No 
significant differences were found for anti-inflammatory cytokines and chemokines 
(Figure 25).  Figure 26 shows the significant differences that still hold when the intact 
subjects are removed from analyses.  The non-significant results obtained by injury 
severity are reported in Figure 27 and Figure 28. 
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Figure 25- Hippocampus anti-inflammatory and unclassified analytes by psychological well-
being.  The average (± standard error of the mean) concentration of anti-inflammatory (A) and unclassified 
(B) cytokines and chemokines in lysate (normalized to total protein concentration) are shown for the 
ANX/DEP, DEP and HEALTH groups.  
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Figure 26- Significant hippocampal differences, reexamined with healthy intacts separated.  The 
average (± standard error of the mean) concentration of analytes in lysate (normalized to total protein 
concentration) found to differ by psychological well-being are shown here again, The graph depicts the 
original data (intacts not removed), with the HEALTH group separated into healthy contused subjects and 
healthy intact subjects to verify possible HEALTH group differences due to intact subjects.  The statistical 
differences reported here are based on post-hoc Sidak comparisons between the ANX/DEP, DEP and 
HEALTH groups, with intacts removed.  As the graphs indicate, even with intacts removed, the 
ANX/DEP group shows increases in both pro-inflammatory cytokines and chemokines.  * p <.05, # 
significant from all others. 
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Figure 28 – Hippocampus anti-inflammatory and unclassified analytes by injury severity. The 
average (± standard error of the mean) concentrations of anti-inflammatory (A) and unclassified (B) 
cytokines and chemokines in lysate (normalized to total protein concentration) are shown for the intact, 
mild, moderate and severe injury groups. 
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Spinal cord 
We assessed the levels of 20 cytokine/chemokines in the spinal cord protein 
supernatant. 4 x 3 ANOVAs ruled out a main effect of injury severity for all the analytes 
except IL-1β, F(3,26)=3.026, p=.047.  However, one-way ANOVAs by injury severity 
revealed a main effect for Il-1α [F(3,32)=4.803, p=.007], IL-1β [F(3,33)=6.361, p=.002], 
IL-2 [F(3,33)=5.456, p=.004], IL-6 [F(3,33)=4.931, p=.006], IL-18 [F(3,33)=3.349, 
p=.028], GRO-KC [F(3,33)=4.452, p=.010], MCP-1 [F(3,33)=5.636, p=.003], and TNF-
α [F(3,33)=2.838, p=.053].  Post-hoc Sidak comparisons revealed that the mild, 
moderate, and severe injury groups showed higher levels of Il-1α, IL-1β, IL-2 (Figure 
29A), and MCP-1 (Figure 29B) than the intact group, ps ≤ .05.  The mild and moderate 
injury groups showed higher levels of IL-6 than the intact group, ps ≤ .05 (Figure 29A).  
The moderate and severe injury groups showed higher levels of GRO-KC than the intact 
group, ps ≤ .05 (Figure 29A).  Finally, the moderate injury group showed higher levels 
of IL-18 and TNF-α than the intact group, ps ≤ .05 (Figure 29B).  No main effects of 
injury severity were observed for the anti-inflammatory or the unclassified 
cytokines/chemokines (Figure 30).  
One-way ANOVAs by psychological well-being revealed a main effect for IL-18 
[F(2,34)=3.426, p=.044], IFN-γ [F(2,34)=3.516, p=.041], MCP-1 [F(2,34)=3.849, 
p=.031], and TNF-α [F(2,34)=4.496, p=.019].  Post-hoc Sidak comparisons revealed that 
the anxious/depressed group showed higher levels of IL-18, MCP-1, TNF-α, IFN-γ than 
the healthy group, (p=.041, p=.066, p=.015 and p=.056 respectively).  
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Figure 30- Spinal cord anti-inflammatory and unclassified analytes by injury severity.  The 
average (± standard error of the mean) concentrations of anti-inflammatory (A) and unclassified (B) 
cytokines and chemokines in lysate (normalized to total protein concentration) are shown for the intact, 
mild, moderate and severe injury groups. 
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Figure 31 shows the significant differences by psychological well-being that still 
hold when the intact subjects are removed from analyses.  Figure 32 shows the 
differences by psychological well-being for all pro-inflammatory cytokines, including 
intacts.  .No main effect of psychological well-being was observed for the anti-
inflammatory or unclassified cytokines/chemokines (data reported in Figure 33).  
 
 
 
 
 
 
Figure 31- Significant spinal cord differences, reexamined with healthy intacts separated.  The 
average (± standard error of the mean) concentration of analytes in lysate (normalized to total protein 
concentration) found to differ by psychological well-being are shown here again, The graph depicts the 
original data (intacts not removed), with the HEALTH group separated into healthy contused subjects and 
healthy intact subjects to verify possible HEALTH group differences due to intact subjects.  The statistical 
differences reported here are based on post-hoc Sidak comparisons between the ANX/DEP, DEP and 
HEALTH groups, with intacts removed.  As the graphs indicate, even with intacts removed, the 
ANX/DEP group shows increases in both pro-inflammatory cytokines and chemokines.  * p <.05. 
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Figure 33- Spinal cord anti-inflammatory and unclassified analytes by psychological well-being. 
The average (± standard error of the mean) concentration of anti-inflammatory (A) and unclassified (B) 
cytokines and chemokines in lysate (normalized to total protein concentration) are shown for the 
ANX/DEP, DEP and HEALTH groups. 
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Discussion 
In this chapter, we assessed a tableau of cytokine and chemokine expression 
peripherally (serum) and centrally (brain and spinal cord) post SCI, to determine whether 
inflammation is associated with depression- and anxiety-like signs post SCI.  Numerous 
human and rodent studies have found inflammation to be involved in depression (Audet 
& Anisman, 2013; Dantzer et al., 2008; Maes, 1999; Maes et al., 1997; van West & 
Maes, 1999; Walker et al., 2014), especially after a central nervous system injury, such 
as a traumatic brain injury (Juengst, Kumar, Failla, Goyal, & Wagner, 2014).  Our 
results provide similar confirmatory evidence for a role of inflammation in depression 
following SCI.  Overall, the data support the hypothesis that the increased incidence of 
depression and anxiety-like signs observed in contused subjects in Chapter III is 
associated with increased levels of pro-inflammatory cytokines in the spinal cord, the 
brain, and the serum.  
Yang et al. (2005) reported SCI severity dependent up-regulation of IL-1β, IL-6, 
and TNF-α mRNAs and proteins in the spinal cord, up to 6 hours post injury. In contrast, 
we found no effect of injury severity on cytokine or chemokine levels either centrally or 
peripherally; only the expected spinal cord increases in contused subjects overall relative 
to intact subjects.  The absence of an injury severity effect is likely due to differences in 
the time of tissue collection.  In our study, we examined central inflammation (spinal 
cord and hippocampi) 25 days post SCI, long after the injury dependent effects on 
inflammation would have subsided, according to Yang et al. (2005).  Only serum levels 
were assessed in the acute phase of injury, at 24 hours post SCI.  Based on 
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immunohistochemical analyses, Yang et al.(2005) suggested that the increased 
inflammation they observed was due to endogenous cells of the spinal cord, not 
peripheral.  Therefore, we might not observe injury severity dependent increases in pro-
inflammatory molecules in the serum.  Indeed, our results suggest that injury severity 
dependent changes in inflammation may only be present transiently, at the level of the 
spinal cord, and may not transfer to an injury severity dependent change in inflammation 
in the periphery, or a long-term injury severity dependent change in inflammation in the 
central nervous system.  
While inflammation did not increase significantly as a function of injury severity, 
we found that peripheral and central inflammation differed among psychological well-
being groups.  Relative to the healthy group, the depressed group showed higher levels 
of several pro-inflammatory cytokines (TNF-α, IL-1β), anti-inflammatory cytokines (IL-
10) and chemokines (GM-CSF, GRO-KC, MIP-2, Fractalkine, and LIX) in the serum.  
In turn, the anxious/depressed group showed higher levels of two pro-inflammatory 
cytokines (IL-1α and TNF-α) in the hippocampus, relative to the healthy group.  The 
anxious/depressed group also showed higher levels of spinal cord pro-inflammatory 
cytokines (IL-18, IFN-γ, and TNF-α) and chemokines (MCP-1) relative to the healthy 
group.  Importantly, the majority of these differences remained even after removing the 
intact subjects from analyses, thus confirming that the differences between the depressed 
and/or anxious/depressed groups and the healthy group were not due simply to a lower 
number of contused subjects in the healthy group.   
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The central increase of pro-inflammatory cytokines in the group of subjects 
identified as anxious/depressed could be explained in two ways.  First, it could be 
explained by a unidirectional relationship between the spinal cord and the brain- spinal 
cord inflammation, through a series of mechanisms, resulting in anxiety-like behavior.  
We know that SCI results in short-term increases of pro-inflammatory cytokines at the 
level of the spinal cord (Yang et al., 2005; Yip & Malaspina, 2012).  Furthermore, it has 
been shown, both in rodent SCI models and in humans, that in some SCI subjects, long-
term increases in serum and spinal cord pro-inflammatory cytokine levels occur as well 
(Beck et al., 2010; Hayes et al., 2002), and it is known that inflammatory stimuli, even 
peripheral, can prime brain microglia to produce pro-inflammatory cytokines (Audet & 
Anisman, 2013; Dantzer et al., 2008).  In our experiment, the increase in spinal cord pro-
inflammatory cytokines immediately following SCI could have primed brain microglia 
to produce pro-inflammatory cytokines.  This sustained SCI inflammation could, in turn, 
have caused anxiety-like behavior. As described in Chapter I (Introduction), the chronic 
elevation of cytokines can induce chronic HPA axis activation, resulting in chronic 
elevation of glucocorticoids and eventually glucocorticoid resistance, loss of HPA axis 
feedback loop inhibition, uncontrolled inflammation, and further HPA axis activation.  
Such a unidirectional mechanism could explain the increased levels of pro-inflammatory 
cytokines in both the spinal cord and the hippocampi of the subset of contused subjects 
identified as anxious/depressed.  
However, the relationship between inflammation in the spinal cord and the brain 
could also be bi-directional.  That is, in addition to the spinal cord inflammation 
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triggering inflammation supraspinally and activating the stress response as summarized 
above, the chronic activation of the stress response and the resulting uncontrolled 
inflammation could have caused generalized increases in central nervous system 
inflammation, including the spinal cord.  In this case, the increased levels of pro-
inflammatory cytokines observed in the spinal cord of anxious/depressed subjects could 
be due both to the SCI itself, and chronic stress.  Our experimental design does not allow 
us to determine whether the relationship between SCI and increased inflammation in the 
central nervous system is unidirectional or bidirectional.  It will be necessary, in the 
future, to conduct pharmacological studies, for example administering anti-inflammatory 
agents at different time points following SCI while assessing psychological well-being 
as well as central and peripheral inflammation, to determine whether anxiety results 
strictly from spinal cord inflammation, or is the result of both spinal cord inflammation 
and perpetuation of inflammation by chronic stress via the brain.  It will likely be a 
combination of both. It will also be useful in the future to examine brain levels of 
serotonin, dopamine, and norepinephrine, to examine how the monoamines traditionally 
associated with depression are affected in the psychological well-being subgroups we 
identified, and examine brain levels of glucocorticoids and glucocorticoid receptors to 
determine whether these are altered in the anxious/depressed subjects.  
This experiment is the first to assess, simultaneously, spinal cord, brain, and 
serum levels of cytokines and chemokines following a spinal cord contusion injury in a 
rodent model.  We have shown that SCI results not only in increased levels of cytokines 
in the spinal cord, but also in the brain, and the serum.  Importantly, we demonstrate that 
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two sub-groups of contused rodents, those identified as exhibiting depression- and 
anxiety-like signs, show increases in cytokine and chemokines both peripherally and 
centrally, even 25 days after the injury.  Although our experiment does not allow us to 
verify a causal role of inflammation in depression and anxiety, the results are of 
particular clinical relevance, as it suggests that in a sub-group of spinal cord injured 
patients, there is an association between chronic inflammation and symptoms of 
depression and anxiety.  To improve the mental health of these patients, it may 
eventually be possible to provide them with treatments for the immune dysregulation, in 
addition to the conventional treatments for depression.   
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CHAPTER V  
ENRICHING THE SOCIAL ENVIRONMENT TO PROMOTE 
PSYCHOLOGICAL WELL-BEING AND RECOVERY POST SPINAL CORD 
INJURY 
 
Introduction 
This experiment explored the effects of group housing on psychological well-
being, recovery of function, and peripheral inflammation after spinal cord injury (SCI).  
The impact of the social environment on inflammation and general health has been noted 
both in animal and human studies.  Chronic social stress, for example, can lead to a 
blunted glucocorticoid response and an elevated immune response, both in rodents and 
humans (Avitsur et al., 2009; Miller et al., 2008; Powell et al., 2013).  Moreover, in 
animal models, group housing has been shown to modulate supraspinal brain-derived 
neurotrophic factor (BDNF) levels (Berrocal et al., 2007; Oztan, Aydin, & Isgor, 2011; 
Ravenelle, Santolucito, Byrnes, Byrnes, & Donaldson, 2014; Venna, Xu, Doran, Patrizz, 
& McCullough, 2014), as well as corticosterone (Moncek, Duncko, Johansson, & 
Jezova, 2004; Ravenelle et al., 2014), 5-HT (Beck & Luine, 2002), and pro-
inflammatory cytokine levels (Krugel et al., 2014; McQuaid, Audet, Jacobson-Pick, & 
Anisman, 2013).  Conversely, social isolation has been found to increase immobility on 
the forced swim test (Brenes & Fornaguera, 2009; Martin & Brown, 2010), increase 
anxiety assessed with open field activity and the elevated plus maze (Chourbaji, Zacher, 
Sanchis-Segura, Spanagel, & Gass, 2005; Ruis et al., 1999), and decrease BDNF levels 
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in the dorsal hippocampus and frontal cortex of pigs (De Vry et al., 2012).  There is also 
strong evidence that social isolation can lead to further excitation of the immune system, 
exacerbating depression and anxiety-like signs.  For example, Jaremka et al. (2013) 
found that healthy adults who perceived themselves as lonely show a great inflammatory 
response in lipopolysaccharide stimulated peripheral blood mononuclear cells following 
acute stress (Jaremka et al., 2013).  Recent studies have also identified social isolation as 
a risk factor for diseases such as stroke (Venna et al., 2012).  Inflammation may affect 
psychological well-being after SCI, as shown in the preceding chapters, but the inverse 
may also be true: psychological well-being, as the studies above indicate, may affect 
inflammation, and thus, SCI recovery.  
The role of the social environment has been well studied in the clinical human 
spinally injured population.  Following SCI, social support is positively associated with 
physical and mental health (Muller, Peter, Cieza, & Geyh, 2012).  Individuals with 
strong social support are less likely to develop chronic pain following SCI (Goossens, 
Dousse, Ventura, & Fattal, 2009; Raichle, Hanley, Jensen, & Cardenas, 2007) and less 
likely to develop secondary complications such as pressure ulcers and urinary tract 
infections (Muller et al., 2012).  Individuals with low perceived social support are more 
likely to develop symptoms of depression and anxiety following SCI (Boekamp et al., 
1996; Chan, Lee, & Lieh-Mak, 2000b; Elliott et al., 1991; Muller et al., 2012).  The 
association between social support and secondary complications following SCI could be 
due to greater compliance with physicians’ directions in patients having social support 
(Bombardier et al., 2004).  However, the association between social support, chronic 
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pain and mental health suggests that the positive effects of the social environment are 
due to more than simply improved treatment compliance.  These observations are of 
particular importance, for SCI leads many patients to experience a decrease in 
psychological well-being, and an increase in perceived loneliness (Lohne & Severinsson, 
2005): the perception of few people who understand them, and in whom they can 
confide.  These psychiatric-epidemiological studies highlight the potential impact of a 
positive environment in the recovery of patients following SCI.   
Given these animal and human findings, we hypothesized that group housing 
could reduce depression and anxiety-like signs in spinally contused rodents.  We 
hypothesized that rats pair-housed following a contusion injury would show reduced 
anxiety- and depression-like signs post injury, lower levels of peripheral inflammation, 
reduced sensitivity to pain, and greater recovery of locomotor function, relative to 
single-housed contused animals.  Notably, there have been no reports on the effects of 
group housing (as the sole intervention) on recovery of function or inflammation 
following SCI.  The experiment reported here, therefore, also provides an initial 
systematic analysis of the effects of pair-housing on recovery of motor and sensory 
function after SCI. 
Methods 
Experimental design 
Rats underwent a moderate spinal cord contusion injury, as described in the 
General Methods.  There were five experimental groups (n=8): (1) contused animals 
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single housed (CONT-SH), (2) contused animals with contused cagemate (CONT-CC), 
(3) contused animal with intact cagemate (CONT-CI), (4) intact animal with contused 
cagemate (INTACT-CI), and (5) intact animal with intact cagemate (INTACT-II).  This 
last group housing condition allowed us to control for the possible confounding effect of 
being exposed to an injured cagemate.  Prior to spinal cord contusion surgery, all rats 
were housed in pairs.  Post-surgery, they either remained pair housed or were single 
housed, depending on the condition to which they were assigned.   
For all subjects, psychological well-being was assessed at baseline with a 
comprehensive battery of tests as well as during Test Phase 1 (days 5 and 10) and Test 
Phase 2 (day 20-21) post injury (See Figure 2).  The intact subjects were tested at ages 
compatible with those of the contused subjects.  The procedures for each of the tests are 
described in detail in the General Methods section (see Behavioral tests).  Locomotor 
function was assessed throughout the 21-day recovery period with the BBB scale (Basso 
et al., 1995).  Tests of sensory function (girdle, tactile and thermal reactivity) were 
conducted during Test Phase 1 (day 11) and Test Phase 2 (day 22).  Blood was also 
collected during each test phase (pre-injury, and days 1, 10, and 24).  At the end of the 
assessment period, subjects received a lethal injection of beuthanasia (100 mg/kg, i.p.).  
Results 
We first used a series of statistical analyses to determine the psychological well-
being of the subjects in the experiment.  As described in Chapter III, a principal 
component analysis was used initially to determine which behavioral measures were 
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correlated with each other.  Next, we ran a hierarchical cluster analysis on the behavioral 
measures retained by the principal component analysis in order to identify the subject 
clusters in our sample.  The hierarchical cluster analysis identified subjects as exhibiting 
depression, anxiety/depression, or as being healthy.  After identifying the psychological 
well-being groups, we ran post-cluster repeated measure analyses of variance 
(ANOVAs) on the behavioral measures retained by the principal component analysis in 
order to confirm the hierarchical cluster group identifications.  Following confirmation 
of the hierarchical cluster groups, we conducted repeated measure ANOVAs on 
additional test variables (not included into the principal component and hierarchical 
cluster analyses), to look for main effects of group housing and psychological well-
being, as well as interaction effects, on anxiety, pain, recovery of function and 
physiological markers. 
Principal component analyses: assessment of test validity for identifying 
psychological well-being  
The principal component analysis produced two components, which 
cumulatively explained 69.19% of the variance between subjects. The first component 
contained the open field activity, social exploration and the shock probe burying test.  
The sucrose preference test loaded on the second component (see Table 6).  Both 
components had Eigenvalues greater than 1, and explained a significant proportion of the 
variance between subjects. They were retained for subsequent analyses. 
  
  
131 
 
Behavioral tests 
Components 
1 2 
Sucrose preference .014 .972 
Social exploration .779 .034 
Open field activity .807 .206 
Shock probe burying  .689 -.217 
 
Table 6 - Components of principal component analyses in Group Housing experiment.  
Component loadings are shown for the behavioral tests retained.  To be retained, behavioral tests had to 
load with >.03 on one component only.  
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Hierarchical cluster analyses: classification of psychological well-being 
Average scores (derived from both Test Phases 1 and 2), for each of the 
behavioral tests retained in the principal component analysis (sucrose preference, social 
exploration, open field activity and shock probe burying), were used in the hierarchical 
cluster analysis.  The dendrogram produced by this analysis showed that subjects 
separated into three psychological well-being clusters, with 12 subjects in Hierarchical 
Cluster (HC) Group 1, 11 subjects in HC group 2, and 16 subjects in HC group 3 (see 
Figure 34).  To identify the psychological well-being characteristics of each cluster 
group, the three groups were compared on each of the behavioral measures retained in 
the principal component analysis, across Test Phase 1 and 2, using repeated measure 
ANOVAs.  Based on their performance on these tests, subjects in Group 1 were labeled 
as exhibiting depression-like signs (or DEP), subjects in Group 2 as exhibiting anxiety 
and depression like signs (or ANX/DEP) and subjects in Group 3 as being healthy (or 
HEALTH).  Baseline differences were significant only for the open field activity test, 
F(2,36)=9.26, p=.001.  For this variable only, repeated measures analyses of covariances 
were conducted.  All post-hocs were conducted with multiple comparison Sidak tests.  
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Figure 34- Hierarchical cluster dendogram, Group Housing experiment. The dendogram 
illustrates the results of the hierarchical cluster analysis, which separated the sample into three main 
clusters (Group 1 (n=12), Group 2 (n=11), and Group 3 (n=16)), based on the subjects’ average 
performance on the behavioral tests retained by the principal component analysis.  The numbers on the y-
axis represent the subjects.  
  
  
134 
 
Post hierarchical cluster comparisons 
Repeated measure ANOVAs revealed a main effect of psychological well-being 
(HC group) for the open field activity test and the social exploration test [F(2,35)=59.45, 
p=.000 and F(2,36)=9.41, p=.001, respectively].  Differences also approached 
significance for the shock probe burying test, F(2,26)=3.36, p=.050 (Figure 35G and 
Figure 35F).  No differences were found for the sucrose preference test (Figure 35A and 
Figure 35B).  For open field activity, subsequent ANOVAs on Days 10 and 21 
confirmed a main effect of psychological well-being at both time points [F(2,35)=39.58, 
p=.000, F(2,35)=37.17, p=.000, for Day 10 and 21 respectively]. Post-hoc analyses 
showed that on both days, the DEP group and the ANX/DEP group displayed a lower 
number of squares crossed in an open field compared to the HEALTH group.  Moreover, 
the DEP group showed reduced open field activity relative to the ANX/DEP group, ps ≤ 
.05 (Figure 35C and Figure 35D). For social exploration, ANOVAs on Days 10 and 21 
separately confirmed that the HC groups differed on social exploration on Days 10 and 
21, [F(2,36)=8.66, p=.001 and F(2,36)=3.21, p=.05 respectively]. Post-hoc analyses 
revealed that both the DEP group and ANX/DEP group showed decreased interaction 
time compared to the HEALTH group on Day 10, ps ≤ .05, Figure 35E.  On day 21, the 
DEP group showed decreased interaction time relative to the HEALTH group, p =.06, 
Figure 35F. 
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Figure 35- Post HC behavioral differences. The average (± standard error of the mean) 
performance of the ANX/DEP, DEP, and HEALTH group are shown on each task.  On Day 10 and 21, the 
DEP and ANX/DEP groups displayed decreased open field compared to the HEALTH group.  The DEP 
group further showed reduced open field activity relative to the ANX/DEP group (C and D).  Both the 
DEP and ANX/DEP group showed decreased social exploration relative to the HEALTH group on Day 10 
(E).  Finally, on Day 21, the DEP group showed a trend towards decreased social interaction relative to the 
HEALTH group (F). * p <.05, # significant from all others. 
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Differences in psychological well-being, pain, recovery of function and 
physiological markers 
Repeated measure ANOVAs were conducted to identify main effects of group 
housing and psychological well-being on Days 10 and 21 separately.  Baseline 
differences were significant only for open field activity and center activity 
[F(2,36)=9.26, p=.001 and F(2,36)=5.22, p=.01, respectively].  For these variables, 
repeated measure analyses of covariances were conducted. However, it is important to 
note that including the baseline as a covariate does not correct fully for the differences 
pre-contusion on these two variables.  Following the comparisons across time, one-way 
ANOVAS were run for both independent variables separately, on Days 10 and 21.  In 
this experiment, one-way ANOVAS were run for both independent variables separately, 
on Days 10 and 21, regardless of whether main effects were found for group housing and 
psychological well-being.  One-way ANOVAs were conducted regardless, because of 
the exploratory nature of this experiment. Finally, post-hocs were conducted with 
multiple comparison Sidak tests to identify group differences on specific test days.  Note 
that for sucrose preference, open field activity, social exploration, and shock probe 
burying, psychological well-being effects are not reported here, as these were already 
reported in the post-hierarchical cluster ANOVAs used to characterize the hierarchical 
cluster subgroups.  Psychological well-being group membership by group housing 
condition is shown in Figure 36. 
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Figure 36- Psychological well-being membership by group housing condition.  This figure shows 
group membership by group housing condition.  
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Depression measures  
In addition to the main effects of open field activity and social exploration found 
by psychological well-being, as per the post hierarchical cluster repeated measure 
analyses run in the previous section (Figure 37), repeated measure ANOVAs also found 
several main effects of group housing on measures of depression. 
Sucrose preference.  A repeated measure ANOVA found no main effect of group 
housing across time for the sucrose preference test.  However, subsequent one-way 
ANOVAs, comparing sucrose preference on Days 10 and 21 separately, found a main 
effect of group housing on Day 21 only, F(4, 34)=4.49, p=.005. Post-hoc Sidak 
comparisons by group housing indicated that the CONT-CC group showed significantly 
higher sucrose preference on Day 21 than the CONT-CI group, and the INTACT-CI 
group, ps ≤ .05.  
Open field activity.  A repeated measure ANOVA revealed a main effect of group 
housing across time for the open field activity test, F(4,33)=10.736, p=.000.  Subsequent 
one-way ANOVAs on Days 10 and 21 separately, found a main effect of group housing 
on Days 10 and 21, [F(4,33)=13.70, p=.000, F(4,33)=5.71, p=.001, on Days 10 and 21 
respectively].  Post-hoc Sidak comparisons by group housing indicated that on Day 10, 
the CONT-CC and CONT-CI groups displayed decreased open field activity relative to 
the INTACT-CI and INTACT-II groups, ps ≤ .05. 
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Figure 37- Depression measures by psychological well-being.  The average (± standard error of 
the mean) performance of the ANX/DEP, DEP, and HEALTH groups are shown on all depression 
measures.  The  DEP and the ANX/DEP groups showed decreased open field activity relative to the 
HEALTH group on Days 10 and 21 (C and D). The DEP group also showed decreased open field activity 
relative to the ANX/DEP group on both days. The ANX/DEP (on Day 21) and the DEP groups (on Days 
10 and 21) showed decreased social exploration relative to the HEALTH group  (E and F). Finally, the 
DEP group showed greater immobility on the forced swim test than the HEALTH group (G). * p <.05, # 
significant from all others. 
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Furthermore, on Day 21, the CONT-SH, CONT-CC and CONT-CI groups 
displayed decreased open field activity relative to the INTACT-CI and INTACT-II 
groups, ps ≤ .05, Figure 38. 
Social exploration.  A repeated measure ANOVA revealed a main effect of group 
housing across time for the social exploration test, F(4,34)=2.92, p=.035.  Subsequent 
one-way ANOVAs, comparing social exploration on Days 10 and 21 separately, 
confirmed a main effect of group housing on Day 10, F(4,34)=6.62, p=.000.  Post-hoc 
Sidak comparisons by group housing indicated that on Day 10, the CONT-CC group 
displayed significantly less social exploration than the INTACT-CI and INTACT-II 
groups, ps ≤ .05.  Furthermore, the CONT-CI group exhibited significantly less social 
exploration behavior than the INTACT-II group, p < .05, Figure 38. 
Forced swim.  One-way ANOVAs, comparing immobility by psychological well-being 
and group housing separately, found a main effect of psychological well-being and 
group housing on Day 24, [F(2,33)=3.511, p=.041, F(4, 31)=11.54, p=.000, 
respectively].  Post-hoc Sidak comparisons by psychological well-being indicated that 
the DEP group spent significantly more time immobile at the forced swim test than the 
HEALTH group, p=.046, Figure 37G.  Post-hoc comparisons by group housing 
indicated that the INTACT-II group spent significantly less time immobile at the forced 
swim test than the CONT-SH, CONT-CC, CONT-CI and INTACT-CI groups on Day 
24, ps ≤ .05, Figure 38. 
.  
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Figure 38- Depression measures by group housing condition.  The average (± standard error of the 
mean) performance of the CONT-SH, CONT-CC, CONT-CI, INTACT-CI and INTACT-II groups are 
shown on all depression measures. The CONT-CC and CONT-CI groups showed decreased open field 
activity relative to the INTACT-CI and INTACT-II groups on Days 10 and 21 (C and D). On Day 21, the 
CONT-SH also displayed decreased open field activity relative to the INTACT-CI and INTACT-II groups 
(D).  The CONT-CC group displayed decreased social exploration relative to the INTACT-CI and 
INTACT-II groups (E). Furthermore, the CONT-CI group also showed decreased social exploration 
relative to the INTACT-II group (E).  Finally the INTACT-II showed decreased immobility on the forced 
swim test relative to all other groups (G). * p <.05, # significant from all others. 
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Anxiety measures  
Shock probe burying.  While a main effect was found for shock probe burying by 
psychological well-being (Figure 39), a repeated measure ANOVA found no main effect 
of group housing across time for the shock probe burying test.  However, subsequent 
one-way ANOVAs, comparing percent time burying on Days 5 and 20 separately, 
indicated a main effect of group housing at both time points [F(4,18)=4.96, p=.007, 
F(4,25)=3.33, p=.026, on days 5 and 21 respectively].  Post-hoc Sidak comparisons by 
group housing condition did not find any significant group differences on Days 5 or 20.   
Center activity.  A repeated measure ANOVA revealed a main effect of group housing 
across time for center activity in an open field, [F(4,33)=7.32, p=.000], as well as a main 
effect of psychological well-being [F(2,35)=6.82, p=.003].  Subsequent one-way 
ANOVAs, comparing center activity on Days 10 and 21 separately, found a main effect 
of psychological well-being and group housing [HC groups: F(2,35)=10.67, p=.000, 
F(2,35)=3.57, p=.039, for Day 10 and 21, respectively; GRH groups: F(4,33)=4.94, 
p=.003, F(4,33)=7.52, p=.000, for Day 10 and 21, respectively]. Post-hoc Sidak 
comparisons by psychological well-being indicated that on Day 10, both the DEP group 
and the ANX/DEP group showed significantly less center activity than the HEALTH 
group, ps ≤ .05.  By Day 21, the DEP continued to show significantly less center activity 
than the HEALTH group, p=.034.  Post-hoc Sidak comparisons by group housing 
indicated that on Day 10, the CONT-CC and the CONT-CI groups showed lower center 
activity than the INTACT -II, and on Day 21, the CONT-SH, CONT-CC, CONT-CI and 
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INTACT-CI groups showed lower center activity than the INTACT-II group, ps ≤ .05, 
(Figure 40).  
 
 
 
 
 
Figure 39- Anxiety measures by psychological well-being.  The average (± standard error of the 
mean) performance of the ANX/DEP, DEP, and HEALTH group, are shown on all anxiety measures.  The 
ANX/DEP group showed greater shock probe burying than the DEP group (A and B). The DEP group 
showed significantly less shock probe burying than the HEALTH group (B). On Day 10, the ANX/DEP 
and DEP showed decreased center activity relative to the HEALTH group (C). On Day 21, the DEP 
continued to show decreased center activity relative to the HEALTH group (D). * p <.05, # significant 
from all others. 
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Pain measures 
Tactile test- paw withdrawal threshold.  Repeated measure ANOVAs found a main 
effect of group housing for the tactile test (paw withdrawal threshold) [F(4,34)=4.93, 
p=.003], but no main effect of psychological well-being. However, subsequent one-way 
ANOVAs, comparing paw withdrawal thresholds on Days 11 and 22 separately, found a 
main effect psychological well-being and group housing on Day 11, [F(2, 36)=5.24, 
p=.010, F(4,34)=4.53, p=.005].  Post-hoc Sidak comparisons by psychological well-
being indicated that on Day 11, the DEP group showed a lower threshold on the motor 
tactile test than the ANX/DEP and the HEALTH groups, ps ≤ .05, Figure 41A. Post-hoc 
Sidak comparisons by group housing indicated that on Day 11, the CONT-CC group 
showed a lower threshold on the motor tactile test than the CONT-SH and the INTACT-
II group, ps ≤ .05, Figure 42A.   
Tactile test- vocalization threshold.  Repeated measures ANOVAs found no main effect 
of psychological well-being (HC group) or group housing (GRH group) effect for 
number of vocalizations on the tactile test, [F(2, 36)=1.71, p=.196, F(4, 34)=1.79, 
p=.153, by HC group and GRH group respectively].  Subsequent one-way ANOVAs did 
not find a main effect of group housing or psychological well-being. 
Tail-flick.  Repeated measure ANOVAs found a main effect of group housing (GRH 
group) for withdrawal latency [F(4,34)=4.18, p=.007], but no main effect of 
psychological well-being.  Subsequent one-way ANOVAs, comparing withdrawal 
latency on Days 10 and 22 separately, found a main effect of group housing on both 
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Days, [F(4,34)=2.77, p=.043, F(4,34)=3.46, p=.018, Days 10 and 22 respectively], but 
no main effect of psychological well-being.  Post-hoc Sidak indicated that on Day 11, 
the INTACT-II group displayed greater withdrawal latency than the CONT-CI group, 
p=.038, Figure 42C.  On Day 22, the INTACT-II group displayed greater withdrawal 
latency than the CONT-CC group, p=.016, Figure 42D. 
Girdle test.  Repeated measure ANOVAs found a main effect of group housing (GRH 
group) for the number of vocalizations on the girdle test [F(4,34)=8.62, p=.000], but no 
main effect of psychological well-being.  Subsequent one-way ANOVAs, comparing 
number of vocalizations on Days 11 and 22 separately, found a main effect group 
housing on Day 11 only, F(4, 34)=5.27, p=.002.  Post-hoc Sidak comparisons by group 
housing indicated that the CONT-SH group displayed a significantly higher number of 
vocalizations on the girdle test than the CONT-CC group, the CONT-CI group, the 
CONT-II group, the INTACT-CI group and the INTACT-II group, ps ≤ .05, Figure 42E.  
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Figure 42- Pain measures by group housing condition.  The average (± standard error of the 
mean) performance of the CONT-SH, CONT-CC, CONT-CI, INTACT-CI and INTACT-II groups are 
shown on the tactile tests. On Day 11, the CONT-CC group showed a decreased paw withdrawal threshold 
relative to the CONT-SH and INTACT-II group (A).  On Day 11, the INTACT-II showed a higher 
vocalization withdrawal threshold relative to the CONT-CI group (C), and on Day 22, relative to the 
CONT-CC group (D).  Finally, the CONT-SH group showed a greater number of vocalizations on the 
girdle test than all other groups on Day 11 (E). * p <.05, # significant from all others. 
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Recovery measures 
Locomotor recovery of function.  Repeated measure ANOVAs revealed a main effect of 
group housing (GRH group), F(4,34)=54.43, p=.000, but no main effect of 
psychological well-being (when excluding the intact subjects).  Subsequent one-way 
ANOVAs also did not find a main effect of psychological well-being.  Post-hoc Sidak 
comparisons by group housing confirmed that the INTACT-CI and the INTACT-II 
groups displayed a significantly higher recovery scores (BBB) than the CONT -SH, 
CONT -CC and CONT-CI, ps ≤ .05, Figure 43. 
Weight gain.  Repeated measure ANOVAs found a main effect of group housing 
[F(4,34)= 54.36, p = .000], and psychological well-being [F(2,36)= 19.63, p = .000]. 
However, subsequent one-way ANOVAs, comparing weight gain by psychological well-
being and group housing separately, found a main effect of group housing,  F(4,34)= 
54.36, p = .000 and a main  effect of psychological well-being, F(2,36)= 19.63, p = .000.  
Post-hoc Sidak comparisons by psychological well-being group revealed that the 
ANX/DEP and DEP groups showed significantly less weight gain than the HEALTH 
group, ps ≤ .05, (Figure 44A).  However, Figure 44B indicates that this effect disappears 
when intact subjects are removed.  Post-hoc Sidak comparisons by group housing 
revealed that the INTACT-CI and the INTACT-II groups showed greater weight gain 
than the CONT-SH, CONT-CC and CONT-CI groups, ps ≤ .05, Figure 45.   
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Figure 44- Weight gain by psychological well-being.  The average (± standard error of the mean) 
weight gain of the ANX/DEP, DEP and HEALTH groups in the 21 days post injury are shown, with 
intacts included (A) and removed (B).  Post-hoc Sidak comparisons by psychological well-being group 
revealed that the ANX/DEP and DEP groups showed significantly less weight gain than the HEALTH 
group (A).  However, B indicates that this effect disappears when intact subjects are removed. * p <.05, # 
significant from all others. 
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Physiological measures 
Alpha-2 macroglobulin.  It was expected that levels of alpha-2 macroglobulin would be 
extremely low in intact subjects.  However, they were not excluded from these analyses, 
because all but two intact subjects fell into the HEALTH group, therefore creating 
highly unequal groups.  This is an inherent limitation of the study given the non-
orthogonality between the two independent variables.  Additionally, because alpha-2 
macroglobulin is an acute phase protein, we expected group differences to be evident 
shortly after the spinal cord injury only.  Therefore, we conducted ANOVAs on days 1, 
10 and 21 separately.  One-way ANOVAs for Days 1, 10 and 21 separately revealed a 
main effect of psychological well-being on Day 1, F(2,33)= 13.91, p = .000.  A main 
effect of group housing was also found on Day 1, F(4,31)= 21.34, p = .000.  Post-hoc 
Sidak comparisons by psychological well-being indicated that on Day 1, the DEP and 
ANX/DEP groups showed higher levels of serum alpha-2 macroglobulin than the 
HEALTH group, ps ≤ .05, (Figure 46A and Figure 46B).  Post-hoc Sidak comparisons 
by group housing indicated that on Day 1, the CONT-SH, CONT-CC, and CONT-CI 
groups showed significantly higher levels of serum alpha-2 macroglobulin than the 
INTACT-CI and INTACT-II groups, ps ≤ .05, (Figure 47A and Figure 47B).   
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Figure 46- Serum alpha-2 macroglobulin levels by psychological well-being.  The average (± 
standard error of the mean) alpha-2 macroglobulin levels of the ANX/DEP, DEP and HEALTH groups are 
shown across the recovery period (A) and for Day 1 post SCI specifically (B).  On Day 1, the DEP and 
ANX/DEP groups showed higher levels of serum alpha-2 macroglobulin than the HEALTH group (B).  * 
p <.05, # significant from all others. 
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Figure 47- Serum alpha-2 macroglobulin levels by group housing condition.  The average (± 
standard error of the mean) alpha-2 macroglobulin levels of the CONT-SH, CONT-CC, CONT-CI, 
INTACT-CI and INTACT-II groups are shown across the recovery period (A) and for Day 1 post SCI 
specifically (B).  On Day 1, the contused groups showed higher levels of serum alpha-2 macroglobulin 
than the two intact groups (B).  * p <.05, # significant from all others. 
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Being housed with a contused cagemate: the caregiver effect 
Given that we observed some unexpected differences between the two group 
housed intact conditions (intact animals housed with a contused animal versus an intact 
animal), we ran another series of exploratory ANOVAs using contrasts to examine the 
differences in behavioral performance post contusion by intact group housing conditions.  
We first ran repeated measures ANCOVAs (baseline covariate) by Group Housing 
condition (GRH).  Next, we ran ANCOVAs on each post contusion day separately:  Day 
10, and Day 21.  Contrasts were conducted to compare INTACT-CI and INTACT-II 
groups.  In graphs, the average score of all contused groups (CONT-SH, CONT-CC, and 
CONT-CI) are shown as a point of reference, but they are not included in the analyses.  
We found two important differences in behavior in intact animals paired with a 
cagemate that received a contusion injury (INTACT-CI) relative to intact animals paired 
with a cagemate that remained intact throughout the experiment (INTACT-II).  In the 
forced swim test, the INTACT-CI group showed significantly greater immobility than 
the INTACT-II group, F(1,34)=15.719, p=.000, Figure 48.  In the open field, we found 
that the INTACT-CI group showed significantly less center activity than the INTACT-II 
group on Day 21, F(1,33)=16.772, p=.000 (Figure 49). 
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Figure 48- Differences in depression-like behavior in intact subjects. The average (± standard 
error of the mean) immobility at the forced swim test is shown for the INTACT-CI and INTACT-II 
groups.  For reference, the contused groups (CONT-SH, CONT-CC, and CONT-CI) have been collapsed 
into one bar, CONT-AV.  The INTACT-CI group showed immobility levels equivalent to those of the 
contused subjects, and greater immobility than the INTACT II group. * p <.05, # significant from all 
others. 
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Figure 49- Differences in anxiety-like behavior in intact subjects. The average (± standard error 
of the mean) center activity is shown for the INTACT-CI and INTACT-II groups.  For reference, the 
contused groups (CONT-SH, CONT-CC, and CONT-CI) have been collapsed into one bar, CONT-AV.  
On Day 21, the INTACT-CI group showed center activity levels equivalent to those of the contused 
subjects, and less center activity than the INTACT-II group. * p <.05, # significant from all others. 
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Discussion 
In this experiment, we again characterized psychological well-being in spinal 
cord injured rats, using behavioral measures of anxiety and depression, and identified 
psychological well-being subgroups by conducting a series of statistical analyses.  
Second, we explored the effect of group housing and psychological well-being on 
measures of depression, anxiety, pain, recovery of function, and inflammation.  We 
hypothesized that group housing would act as a form of social enrichment, increasing 
psychological well-being and decreasing inflammation. 
Using the principal component and cluster analyses based on behavioral 
measures of depression and anxiety, we determined that 30.7% of rodents exhibited a 
depression-like profile, consistent with both the results of an earlier depression study 
(Luedtke et al., 2014), and the results of the Injury Severity and Stress experiment 
(Chapter 2).  Another 28.2% of rodents exhibited an anxiety and depression-like profile.  
The subjects identified as depressed were equally distributed among the contused 
groups: CONT-SH, CONT-CC and CONT-CI.  In fact, no intact subject (INTACT-CI or 
INTACT-II) was identified as depressed by the hierarchical cluster analyses.  The 
majority of subjects identified as anxious/depressed were also contused subjects.  Only 
two intact subjects were identified as anxious/depressed.  It is worth noting that although 
the overall incidence of depression-like signs (30.7%) in this experiment is similar to 
that of Chapter III, the number of contused subjects falling into non-healthy categories 
(depressed and anxious/depressed) is markedly higher than in the Injury Severity and 
Stress chapter (Chapter III).  This may in part be due to the fact that in the present 
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analyses, the principal component analysis and the hierarchical cluster analysis included 
a much larger number of intact subjects relative to the total sample size than in Chapter 
III.  This high number of intact subjects, most of which generally show higher 
psychological well-being than contused subjects, may have driven the hierarchical 
cluster analysis to cluster a larger number of contused subjects into separate groups from 
the intact subjects, which were then identified, based on ANOVAs, as the depressed and 
anxious/depressed clusters.   
Interestingly, similar to the results of Chapter III, we again found a relationship 
between anxiety and depression-like signs and mechanical allodynia following SCI.  On 
Day 11, subjects fitting a depressed profile displayed a significantly lower paw 
withdrawal threshold at the tactile test than the healthy subjects.  Moreover, the results 
indicated that both the anxious/depressed and the depressed subjects showed higher 
levels of serum alpha-2 macroglobulin levels than the healthy subjects.  It must be noted, 
however, that in this experiment, the intact animals were not excluded from alpha-2 
macroglobulin analyses, because all but two intact subjects were in the healthy group.  
Removing intact subjects would have rendered groups highly unequal and impeded 
analyses of variance.  A significantly larger sample would have been necessary to ensure 
equal groups.  Despite this, and given that the previous behavioral experiment (see 
Chapter III) found a main effect of psychological well-being for serum alpha-2 
macroglobulin levels one day post injury, these data do point again to a relationship 
between decreased psychological well-being, increased pain sensitivity, and increased 
peripheral inflammation.   
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With regards to social enrichment, we found that group housing did not improve 
recovery following SCI.  Our results also indicate that, surprisingly, housing a contused 
animal with a cagemate does not in itself improve psychological well-being.  
Depression-like signs did not differ significantly among single housed contused subjects 
and contused subjects housed with another contused subject or with an intact animal.  On 
measures of anxiety, we found that all contused subjects, particularly the group housed 
contused subjects (either with a contused cagemate or an intact cagemate), showed 
increased passive anxiety: decreased center activity in an open field, decreased center 
time, and/or decreased center squares crossed.  As others have suggested (Burke et al., 
2007), we also found that group housing did not improve recovery of locomotor function 
in contused subjects.  
While group housing did not affect psychological well-being or recovery for the 
contused subjects, we did find an unexpected effect of this variable in the intact groups.  
One of the most interesting findings in the current study was the evidence for a 
“caregiver effect.”  Rather than protecting the contused subject against the decreased 
psychological well-being effects of a contusion injury, housing a contused subject and an 
intact subject together triggered depression- and anxiety-like signs in the physiologically 
intact subjects.  For example, we observed significantly less immobility on the forced 
swim test in intact animals housed with an intact cagemate relative to all other groups, 
including intact cagemates housed with a contused subject.  This suggests that intact 
animals are affected by the presence of an injured cagemate.  Remarkably, being paired 
with an injured animal results in intact animals showing a level of learned helplessness 
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comparable to that of contused subjects.  Further, we observed that the intact animals 
housed with an intact cagemate showed significantly more center activity in an open 
field than all other groups, including the intact animals housed with a contused 
cagemate.  These intriguing results indicate that the psychological well-being of intact 
animals is affected by the presence of an injured cagemate.  
This appears to mirror the effect of caregiving in humans.  In effect, providing 
care for a long-term home care relative suffering from Alzheimer’s, cancer, dementia, or 
SCI, has been shown to be a source of chronic stress, and is associated with depression 
and anxiety.  Forty to 50% of caregivers for spinal cord injured relatives experience 
significant depressive symptoms (Arango-Lasprilla et al., 2010; Rodakowski, Skidmore, 
Rogers, & Schulz, 2013).  In addition to this, caregivers report general reduction in 
quality of life (Graca, Nascimento, Lavado, & Garanhani, 2013) and overall 
psychological well-being (Gajraj-Singh, 2011).  Furthermore, caregiving can affect the 
immune system.  A systematic review of 37 dementia caregiver studies found that 
caregiving was consistently associated with elevated stress and inflammation (Fonareva 
& Oken, 2014).  Caregivers of dementia relatives, for example, show increased levels of 
pro-inflammatory cytokines such as IL-6 (Kiecolt-Glaser et al., 2003), inflammation 
markers such as C-reactive protein (Miller et al., 2008), as well as up-regulation of the 
inflammation-related transcription factor NF-κB (Hänsel, Hong, Cámara, & von Känel, 
2010; Miller et al., 2008).  Although we observed no serum alpha-2 macroglobulin level 
increases in the intact subjects housed with contused cagemates, it would be interesting 
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to further explore whether inflammation plays a role in the caregiver effect we observed 
in future studies.   
To our knowledge, this experiment is the first to explore the effects of social 
enrichment on psychological well-being following a spinal cord contusion injury in a 
rodent model.  In contrast to the various human clinical studies reporting a positive 
association between social support and psychological well-being post SCI, we found that 
housing a contused rodent with a cagemate did not improve psychological well-being 
following SCI.  One important limitation of this study was the uneven number of 
subjects in each sub-group (group housing condition by psychological well-being), as 
evident in Figure 36.  Ideally, we would have had an equal number of subject in each 
sub-group to run 2-way ANOVAs.  However, this would have required running a large 
number of additional subjects, as the psychological group membership of each subject 
could only be determined on Day 10 post SCI, and the group housing conditions were 
assigned on the day of surgery.  Intriguingly, however, we observed a “caregiver effect”, 
with decreased psychological well-being in intact animals housed with contused animals.  
In the future, an experimental animal model of group housing post SCI such as ours may 
be instrumental in studying the mechanisms underlying the mental and physical health 
effects associated with caring for family member experiencing SCI or another chronic 
health condition.   
  
166 
 
CHAPTER VI  
GENERAL DISCUSSION AND CONCLUSION 
 
In this dissertation, we examined two inverse relationships between spinal cord 
injury (SCI) and psychological well-being: (1) that SCI affects psychological well-being, 
and (2) that psychological well-being affects SCI.  Chapters III and IV focused on the 
former relationship, and Chapter V explored the latter.  To assess whether SCI 
influences psychological well-being, we first characterized psychological well-being 
post SCI at the behavioral level as a function of injury severity, and assessed pain 
reactivity and general peripheral inflammation (Chapter III).  We found that 
psychological well-being decreases significantly following SCI, but not clearly as a 
function of injury severity.  Decreased psychological well-being was associated with 
increased serum levels of alpha-2 macroglobulin, a biomarker of peripheral 
inflammation in rats, as well as reduced thymus weight, and increased pain reactivity.  
These results suggested that SCI may impact the immune system which then contributes 
to decreased psychological well-being following SCI.   
To investigate this further, in Chapter IV, we assessed the levels of 27 cytokines 
and chemokines peripherally and centrally, in the serum, brain and spinal cord tissue of 
the subjects from Chapter III.  While almost no effects of injury severity were observed 
in the serum, we noted a clear effect of psychological well-being, with the depressed 
group showing higher levels of several pro-inflammatory cytokines and chemokines on 
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Day 1 (GM-CSF, GRO-KC, MIP-2, TNF-α, IL-1β, IL-10, Fractalkine, and LIX) and 
Day 24 (GM-CSF and IL-1β), relative to the healthy group. 
In the hippocampi also, no effects of injury severity were observed.  
Interestingly, however, cytokine and chemokine levels differed significantly by 
psychological well-being group, with the anxious/depressed group showing higher levels 
of IL-1α and TNF-α than the healthy group.  Finally, in the spinal cord, we found that, as 
expected, SCI resulted in an increase in several cytokines and chemokines (IL-1α, IL-1β, 
IL-2, IL-6, IL-18, GRO-KC, MCP-1, and TNF-α), relative to intact animals.  Moreover, 
we found psychological well-being differences similar to those found in the brain: the 
anxious/depressed group showed higher levels of IL-18, IFN-γ, MCP-1, and TNF-α than 
the healthy group.  These results indicated that in anxious/depressed subjects, anxiety, 
may maintain high levels of pro-inflammatory cytokines and chemokines in the central 
nervous system, even 25 days after the injury.  Our results confirmed our hypothesis, 
that SCI results in increased cytokine and chemokine levels, and that these are associated 
with decreased psychological well-being.   
In Chapter V, we explored the inverse relationship; that increased psychological 
well-being may modulate SCI recovery.  We used group housing, as a modulator of 
psychological well-being, to examine the effects of psychological well-being on 
recovery from SCI.  We found that, surprisingly, housing a contused animal with a 
cagemate does not in itself improve psychological well-being.  Depression-like signs did 
not differ significantly among single housed contused subjects and contused subjects 
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housed with another contused subject or with an intact animal.  We also found that all 
contused subjects showed increased passive anxiety.  However, intriguingly, we found 
evidence for a “caregiver effect.” Rather than protecting the contused subject against the 
decreased psychological well-being effects of a contusion injury, housing a contused 
subject and an intact subject together triggered depression- and anxiety-like signs in the 
physiologically intact subjects.  These results are reminiscent of the effect of caregiving 
in humans, where providing care for a long-term home care relative can be a source of 
chronic stress, and is associated with depression and anxiety.   
In sum, our data suggest that SCI, by activating the immune system, may hinder 
psychological well-being, potentiating the development of depression and anxiety-like 
signs post injury, as well as pain.  Moreover, psychological well-being may in turn 
influence the physical course of recovery by modulating immune system activation in 
the long-term.  Figure 50 illustrates the main findings of this dissertation, and the 
relationships we propose to have uncovered between the various components studied 
within it: SCI, inflammation, depression, anxiety, and pain.  In the following sections, 
we will review the relationships between SCI, psychological well-being, inflammation, 
and pain based on the results obtained in our three studies (Chapters III, IV, and V), and 
discuss their clinical relevance.   
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Spinal cord injury results in distinct depression sub-types 
Approximately 60% of spinal cord injured patients suffer from depression (Shin 
et al., 2012) or anxiety (Post & van Leeuwen, 2012) at some point following the injury.  
Consistent with the clinical reports, in Chapter III, we found that 63.8% of contused 
rodents presented depression or anxiety-like signs following SCI.  Specifically, one 
subgroup of contused rodents exhibited a purely depression-like profile (30.5% of 
contused subjects), and a second subgroup of contused rodents exhibited a profile of 
both depression and anxiety-like signs combined (33.3%).  In Chapter V, the number of 
contused subjects exhibiting a depression-like profile and an anxiety/depression-like 
profile were higher.  Fifty-two percent of contused subjects were identified as depressed, 
and 39% were identified as anxious/depressed.  This may in part be explained by the fact 
that this experiment included a much larger number of intact subjects relative to the total 
sample size than Chapter III.  This high number of intact subjects, most of which 
generally show few depression and anxiety-like signs, may have driven the hierarchical 
cluster analysis to cluster a larger number of contused subjects into separate groups from 
the intact subjects, which were then identified, based on ANOVAs, as the depressed and 
anxious/depressed clusters.  Nonetheless, in both Chapters III and V, the depressed sub-
group showed decreases in various behavioral tests designed to mirror the DSM-IV 
criteria for depression in humans, such as psychomotor reduction, decreased interest in 
social interactions, and passive anxiety.  In turn the anxious/depressed sub-group showed 
certain depression-like signs, such as anhedonia, psychomotor reduction, decreased 
interest in social interactions, as well as active and passive anxiety.  Despite the 
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differences in incidence of depression and anxiety in Chapters III and V, in both 
chapters, we observed the same three distinct sub-groups:  subjects with no depression or 
anxiety (healthy), subjects with depression-like signs only (depressed), and subjects with 
a combination of depression- and anxiety-like signs (anxious/depressed). 
The incidence of depression in Chapter III was also commensurate with a 
previous study in our laboratory.  Luedtke et al. (2014) found that 34.6% of contused 
subjects displayed a behavioral profile characteristic of depression.  However, Luedtke 
et al. (2014) did not assess anxiety, and the hierarchical cluster analyses identified only 
two clusters of animals in these data.  In the present experiments, the unrestricted 
hierarchical cluster analyses separated the data into three clusters with the third cohort 
representing an anxious/depressed cluster.  The identification of a third cluster of 
subjects in the current study may have been due to one important methodological 
difference in the two studies.  In Luedtke et al. (2014), no blood draws were performed, 
whereas in the present experiment, blood draws were performed prior to the contusion 
injury, and on days 1, 10 and 21 post injury.  We suspect that the repeated blood draws, 
in combination with the invasive contusion surgery, may have acted as a stressor to 
increase anxiety-like behavior.   
While methodological differences may have resulted in the manifestation of 
anxiety-like signs, similarly to Luedkte et al (2014), we found no relationship between 
psychological well-being and physical function post SCI.  Locomotor recovery, as 
assessed by the BBB scale, did not differ based on psychological well-being.  
  
172 
 
Furthermore, performance on the behavioral tests of depression- and anxiety-like signs 
did not decrease as a function of injury severity.  In fact, the severe injury group 
displayed greater movement in some tests, such as the open field activity test.  This is of 
great relevance, for it indicates that the differences we observed between psychological 
well-being subgroups are not due simply to differences in motor ability.  
Spinal cord injury results in increased inflammation 
One of the primary aims of this dissertation was to investigate the relationship 
between inflammation and psychological well-being.  As predicted, we found that SCI 
results in increased inflammation both peripherally (Chapters III, IV and V) and 
centrally (Chapter IV).  In Chapter III, we observed significant increases in serum alpha-
2 macroglobulin, an acute phase protein, in contused subjects one day post SCI.  These 
results were replicated in Chapter V, in which all contused subjects, regardless of 
housing condition, displayed higher levels of serum alpha-2 macroglobulin than the 
intact animals on Day 1 post SCI.  However, in Chapter IV, we found that the cytokine 
and chemokine levels of the contused subjects were only significantly increased in the 
spinal cord.  Relative to the intact group, the contused groups showed higher levels of 
IL-1α, IL-1β, IL-2, MCP-1, IL-6, GRO-KC, IL-18 and TNF-α.  In the serum and the 
hippocampi, although some trends emerged, we found no significant increases in 
cytokine and chemokine levels overall in the contused groups relative to the intact 
group, except for serum MCP-1, which was increased in the moderate and severe injury 
groups relative to the intact group.  In contrast, Hayes et al. (2002) reported elevated 
serum IL-2 and TNF-α in chronic spinal cord injured patients (injury experienced 12 
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months earlier or more) relative to healthy, aged-matched controls. We have found two 
possible explanations for the discrepancy between these results.  First, Hayes et al. 
(2002) found that the serum increase in the pro-inflammatory cytokines was manifest in 
a subset of spinal cord injured patients only.  Similarly, we found that subsets of SCI 
rodents showed elevated serum cytokine and chemokine levels 24 days post SCI: the 
subjects identified as depressed.  Therefore, although our results appear, at first glance, 
to indicate that SCI does not result in peripheral nor brain increases of cytokine and 
chemokine levels, it does, but only in a subset of contused subjects.  Second, Hayes et al. 
used enzyme-linked immunosorbent assays (ELISAs) to assess serum IL-2 and TNF-α 
levels.  Because we sought to obtain a broad picture of pro- and anti- inflammatory 
cytokine and chemokine levels post SCI, and given that we were limited by small serum 
samples, we used multiplex assays, rather than ELISAs.  Recent comparison studies and 
unpublished data presented at the 21st annual meeting of the 
PsychoNeuroImmunological Research Society (2014) indicate that although multiplex 
assays provide high-sensitivity detection of multiple cytokines simultaneously, their 
ability to provide absolute changes in cytokines is limited, and variations between kits 
are generally higher in multiplex assays than the traditional ELISAs (Breen, Perez, 
Olmstead, Eisenberger, & Irwin, 2014; Breen et al., 2011).  It is therefore possible that 
differences in serum and brain cytokines and chemokines would have been observed 
among injury severity groups had we used ELISAs.  However, the clear differences we 
observed among psychological well-being groups in these same samples, as well as in 
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the spinal cord, reinforce the reliability of the assays conducted in this dissertation, and 
suggest this explanation is unlikely. 
Further, despite significant increases in spinal cytokine expression with SCI, we 
did not find that cytokine nor chemokine levels increased as a function of injury severity. 
This contrasts with our original hypothesis, but was likely affected by the time of tissue 
collection.  In our study, we examined central inflammation (spinal cord and 
hippocampi) 25 days post SCI.  Only serum levels were assessed in the acute phase of 
injury, at 24 hours post SCI.  Yang et al. (2005) reported increases in inflammation as a 
function of SCI severity in spinal cord samples; however, these were collected in the 
hours following injury.  Furthermore, Yang et al.’s immunohistochemical evidence 
suggested that the increased inflammation observed was due to endogenous cells of the 
spinal cord, as opposed to cells in the periphery.  Our results suggest that such injury 
severity dependent changes in inflammation may only be present transiently, at the level 
of the spinal cord, and may not transfer to an injury severity dependent change in 
inflammation in the periphery, or a long-term injury severity dependent change in 
inflammation in the central nervous system.   
However, similar to Hayes et al. (2002), who found that a subpopulation of 
spinal cord injured patients show increased serum levels of pro-inflammatory cytokines 
more than one year after the injury, we found elevated serum, hippocampal, and spinal 
cord cytokine and chemokine levels in subsets of SCI rodents even 25 days post SCI.  
Our studies extend the clinical findings to a rodent model of SCI, not only verifying that 
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in rats, like in humans, a subset of subjects show long-term increases in peripheral 
inflammation, but also demonstrating that this inflammation extends to the brain and the 
spinal cord.  Moreover, we have shown that the subsets of subjects with increased 
cytokine levels also exhibit a distinct behavioral profile associated with depression and 
anxiety.   
Site of inflammation varies by depression sub-type 
In Chapter III, we found both depression and anxiety to be associated with higher 
levels of an acute phase protein, alpha-2 macroglobulin on Day 1 post SCI.  Consistent 
with the literature indicating that thymus weight decreases with depression (Leonard & 
Song, 1996; Song & Leonard, 2000), we also found that at the time of sacrifice, the 
thymus weight of depressed subjects was significantly smaller than that of the healthy 
subjects.  Similarly, human studies have found depression and anxiety to be associated 
with higher levels of circulating C-reactive protein, an acute phase protein equivalent to 
alpha-2 macroglobulin in rats (Copeland, Shanahan, Worthman, Angold, & Costello, 
2012; Howren et al., 2009).  However, when we examined the inflammation changes 
post SCI by psychological well-being sub-group more closely in Chapter IV, we found 
two interesting and distinctive patterns: the purely depressed sub-group showed 
increased inflammation in the periphery, whereas the anxious/depressed group showed 
increased inflammation in the central nervous system.    
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Depression post spinal cord injury is associated with peripheral inflammation  
Juengst et al. (2014) have reported increased levels of inflammation in the 
cerebrospinal fluid of traumatic brain injury patients exhibiting posttraumatic 
depression.  In Chapter III, we found that the sub-group of subjects identified as 
exhibiting purely depression-like signs showed increased serum levels of several pro-
inflammatory cytokines and chemokines in both the acute and chronic phase of injury 
(Days 1 and 24 post SCI respectively) only.  On Day 1, relative to the healthy group, the 
depressed group showed higher serum levels of GM-CSF, GRO-KC, MIP-2, TNF-α, IL-
1β, IL-10, Fractalkine, and LIX.  On Day 25, relative to the healthy group, the depressed 
group showed higher serum levels of GM-CSF and IL-1β. These results fit well the body 
of literature both in humans and rodents suggesting an inflammatory basis for depression 
(Audet & Anisman, 2013; Dantzer et al., 2008; Maes, 1999; Maes et al., 1997; van West 
& Maes, 1999; Walker et al., 2014), particularly after a central nervous system injury or 
illness (Juengst et al., 2014).   Surprisingly, we did not find any increases in cytokines 
and chemokines in the hippocampi of depressed subjects.  In hindsight, it is likely that 
this depression sub-type is associated with changes in brain areas other than the 
hippocampi, as hippocampal changes are mostly observed in human depressed patients, 
who often have comorbid anxiety, and in animal models in which depression is induced 
with chronic stress exposure (Marsden, 2013; Price & Drevets, 2010).  In a meta-
analysis of 23 human voxel-based morphometry studies examining brain changes 
associated with major depressive disorder, Bora et al. (2012) found that whereas 
depression with comorbid anxiety was characterized by significantly less gray matter in 
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areas of the limbic system, depression without comorbid anxiety was characterized by 
significantly less gray matter in the frontal cortex and the anterior cingulate cortex.  In 
future studies, it will be necessary to examine inflammation levels in brain regions 
known to be affected in depression with, and without, comorbid anxiety. 
Although our results do not allow us to state that there is a causal relationship 
between increased peripheral cytokine levels and depression, they provide a first line of 
evidence in that direction.  As reviewed in the introduction, an extensive literature exists 
on the causal role of inflammation in depression, both animal and human (Capuron et al., 
2001; Maes et al., 2011; van West & Maes, 1999).  Human studies of SCI commonly 
observe depression post SCI, but are unable to identify clear predicting factors, for they 
are faced with a multitude of psychosocial variables such as financial difficulties and 
loss of independence.  In this dissertation, with the use of an animal model, we avoided 
the confounding psychosocial factors.  We were therefore able to demonstrate that even 
in a context devoid of psychosocial factors, SCI results in depression in a sub-group of 
injured subjects.  Our results also revealed that increased levels of peripheral pro-
inflammatory cytokines post SCI were associated with post SCI depression.  Similar 
changes in serum levels of pro-inflammatory cytokines are reported in a subgroup of 
patients with depression (Felger & Lotrich, 2013; Howren et al., 2009).  A meta-analysis 
of 51 studies conducted between 1967 and 2008, examining the relationship between C-
reactive protein, IL-6, IL-1 and depression found, consistently, a relationship between 
these variables. Certainly, it must be recognized that publication bias may have 
prevented negative findings from being published.  Nonetheless, taken together, the 
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existing human literature and our original findings, suggest that in the human SCI 
population, a sub-group of patients may experience depressive symptoms due to post 
SCI dysregulations in peripheral inflammation, rather than to purely psychosocial 
factors.   
Importantly, we do not claim that monoamine and hypothalamic-pituitary-
adrenal (HPA) axis dysregulation are not involved in depression following SCI.  Rather, 
we propose that sub-types of depression exist, and that in certain sub-types, the 
molecular mechanisms underlying the development and maintenance of depression 
involve inflammation.  However, it is important to keep in mind that simply using a 
peripheral biomarker of inflammation, such as C-reactive protein, to identify patients 
falling into this depression sub-group is not be sufficient.  Many recent studies continue 
to further uncover the complex role of inflammation in depression, for example 
demonstrating that inflammation is in itself neither necessary nor sufficient to diagnose 
depression (Raison & Miller, 2013).  In effect, many individuals who suffer from 
inflammatory illnesses, such as, for example, rheumatoid arthritis, are not depressed; and 
inversely, many individuals suffering from depression may show no dysregulations in 
inflammatory levels.  Nonetheless, biomarkers of inflammation should be incorporated 
in the current diagnosis of depression post SCI, so that spinal cord injured patients 
suffering from depression due to post SCI inflammation dysregulation specifically may 
receive a personalized treatment.   
  
179 
 
Anxiety post spinal cord injury is associated with central inflammation  
Central nervous system inflammation is associated with anxiety-like behavior.  
Monocyte recruitment to the brain has been shown to result in anxiety-like behavior in a 
mouse model of chronic social stress, repeated social defeat (Wohleb, Powell, Godbout, 
& Sheridan, 2013).  In a rat model of post-traumatic stress disorder also, anxiety-like 
behavior was associated with elevated pro-inflammatory cytokines in the hippocampus 
(Wilson et al., 2013).  Similar findings have been reported in the spinal cord.  For 
example, repeated social defeat results in spinal up-regulation of inducible nitric oxide 
synthase (iNOS) and cyclooxygenase-2 (COX-2), two pro-inflammatory molecules, as 
well as hyperalgesia, and anxiety in mice (Rivat et al., 2010).  Likewise, in our study, the 
sub-group of subjects identified in Chapter III as exhibiting both depression and anxiety-
like signs showed increased levels of several pro-inflammatory cytokines and 
chemokines in the hippocampi and in the spinal cord (Chapter IV).  The 
anxious/depressed group showed increased levels of Il-1α and TNF-α in the hippocampi 
and increased levels of IL-18, IFN-γ, MCP-1, and TNF-α in the spinal cord.  These 
results suggest that in this sub-group of subjects, anxiety maintained high levels of pro-
inflammatory cytokines and chemokines in the central nervous system, even 24 days 
after SCI.  To the best of our knowledge, this is the first study to examine changes in 
brain cytokines following SCI.  
As mentioned in the Introduction to this dissertation (Chapter I), a chronic 
activation of the HPA axis can lead to chronically elevated circulating glucocorticoids.  
In our study, repeated saphenous vein blood collections combined with SCI may have 
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acted as a chronic stressor, thus activating the HPA axis chronically. This, in turn, may 
have caused glucocorticoid resistance, thereby undermining the anti-inflammatory 
actions of glucocorticoids.  As a result, production of pro-inflammatory cytokines would 
not be inhibited, and inflammation levels would be increased and sustained (see Figure 
1).  This may, in part, explain the increased levels of pro-inflammatory cytokines in the 
central nervous system of subjects identified as anxious/depressed.  In addition to this, it 
is possible that the acute increase in inflammation due to SCI, both peripherally and 
centrally, further activated the HPA axis, reinforcing the cycle described above, as 
circulating pro-inflammatory cytokines are known to activate the HPA axis (Pace et al., 
2007; Rosenblat et al., 2014).  
The increase in pro-inflammatory cytokines and chemokines in the spinal cord 
specifically, provides evidence that, as proposed in Maldonado Bouchard (2014), anxiety 
may result in increased inflammation post SCI, including in the spinal cord, and it may 
be maintained into the chronic phase of injury, thereby modulating SCI recovery in the 
long-term.  This has important clinical implications, as it suggests that spinal cord 
injured patients displaying prolonged and severe signs of anxiety may not only be 
experiencing mental distress, but that anxiety in turn may, inadvertently, be causing 
immune changes at the level of the lesioned spinal cord.  Such changes could contribute, 
at the cellular level, to neurotoxicity and apoptosis, and to the development of 
neuropathic pain.  In our studies, we did not observe decreases in locomotor recovery 
associated with increased inflammation that could be suggestive of apoptosis at the level 
of the spinal cord.  We also did not find a direct correlation between pain measures and 
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inflammation, although we noted that the subjects who displayed decreased paw 
withdrawal thresholds on the tactile reactivity test (anxious/depressed) were also the 
subjects who showed greater central inflammation, both in the hippocampi and the spinal 
cord.  Inflammation is known to be associated with chronic pain (Walker et al., 2014), 
and most chronic pain is of a spontaneous nature.  Some have argued that the 
conventional tests used to assess pain, which require application of a stimulus, such as 
von Frey filaments, do not accurately report chronic pain (Sufka, 1994).  Because they 
require tactile stimuli, these tests are thought to only accurately assess evoked pain, not 
spontaneous pain.  The use of a conditioned place paradigm paired with an analgesic 
agent has been proposed to uncover spontaneous pain without the application of any 
tactile stimulus (King et al., 2009; Sufka, 1994).  In the future, it would be interesting to 
use this type of conditioned place paradigm with our rodent model of depression and 
anxiety post SCI to further examine whether an association exists between central 
inflammation, anxiety, and neuropathic pain.  
Interplay between pain, inflammation and psychological well-being  
The results obtained in both Chapter III and Chapter V suggest a relationship 
between inflammation, pain and depression and fit well with psychoneuroimmunological 
studies proposing that inflammation may be the common factor underlying both 
depression and pain in patients exhibiting comorbid depression and chronic pain (Walker 
et al., 2014).  In Chapter III, we found that the subjects identified as depressed not only 
showed decreased psychological well-being, but also showed decreased paw withdrawal 
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thresholds on the tactile test, and increased peripheral inflammation, as measured by 
serum alpha-2 macroglobulin levels.   
In Chapter V, we found a similar relationship between anxiety and depression-
like signs and mechanical allodynia following SCI.  On Day 11, subjects fitting a 
depressed-like profile displayed a significantly lower paw withdrawal threshold at the 
tactile test than the healthy subjects.  Moreover, the results indicated that both the 
anxious/depressed and the depressed subjects showed higher levels of serum alpha-2 
macroglobulin levels than the healthy subjects.  Together, these findings point to a 
relationship between decreased psychological well-being, increased pain sensitivity, and 
increased peripheral inflammation.   
Recent studies have revealed the therapeutic potential of common anti-
inflammatory agents, non-steroidal anti-inflammatory agents in particular, such as the 
common aspirin, for the treatment of mental illness (Berk et al., 2013).  By inhibiting 
COX-1 and COX-2 and triggering lipoxin production (anti-inflammatory eicosanoids), 
aspirin is thought to result in the inhibition of neutrophil and eosinophil activation, as 
well as the regulation of NF-κB activation, a pro-inflammatory cytokine gene 
transcription factor, thus regulating inflammation and regulating cytokine-induced 
oxidation, two pathophysiological processes involved in depression (Berk et al., 2013).  
Supporting this idea, Guan et al. (2014) have found that aspirin administered i.p. 
following a 15 minute forced swim test session reduced immobility on the forced swim 
test 24 hours later, as well as reduced serum levels of pro-inflammatory cytokines 
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following the second test.  If our interpretation of our results from this dissertation is 
correct, and inflammation is at the crossroads between decreased psychological well-
being and pain following SCI, it suggests that spinal cord injured patients suffering from 
depression and chronic increases in peripheral and central inflammation may not only 
benefit from a personalized therapy to control immune dysregulation for the treatment of 
depression, but also for the treatment of chronic pain.   
Social environment post spinal cord injury and the caregiver effect 
In Chapter V, we found that group housing did not improve recovery of 
locomotor function in contused subjects, nor did it promote psychological well-being.  
Depression-like signs did not differ significantly among single housed contused subjects 
and contused subjects housed with another contused subject or with an intact animal.  
All contused subjects, particularly the group housed contused subjects (either with a 
contused cagemate or an intact cagemate), actually showed increased passive anxiety.  
At first glance, these results contradict the studies reporting social enrichment to be 
associated with beneficial effects, such as decreased anxiety-like signs, increased levels 
of BDNF in the amygdala and hippocampus (Ravenelle et al., 2014), decreased 
depression (Grippo et al., 2014; Krugel et al., 2014) and lowered basal heart rate (Azar, 
Sharp, & Lawson, 2011).  However, three possible explanations exist for these findings.   
The immediate interpretation is that group housing does not improve 
psychological well-being in spinally injured rats.  Instead, by decreasing the space 
available in the cage for the contused subject to move, decreasing access to food and 
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water, and increasing the likelihood of harmful physical contacts post injury, it may be a 
source of physical stress.  This stress may,  in fact contribute to the increased incidence 
of depression and anxiety found in this experiment relative to the experiment of Chapter 
III and Luedtke et al. (2014).  Consistent with this idea, social enrichment, in the form of 
housing 10 rats in a cage, has been reported to result in increased levels of corticosterone 
and, increased anxiety-like signs (Moncek et al., 2004).  The fact that we observed 
decreased body weight in group housed contused subjects also supports this explanation, 
although the literature on the health promoting effects of social enrichment (Ravenelle et 
al., 2014) would contradict this interpretation.  
The second explanation is that because spinal cord contusion is a traumatic injury 
of a severe nature, the potentially mild benefits of social interventions, even when 
present, may remain imperceptible.  In effect, our findings in Chapter III and IV 
demonstrate that SCI results in depression- and/or anxiety-like signs in nearly 64% of 
contused subjects, as well as increases in inflammation in the spinal cord, the serum, and 
the brain.  The positive effects of social enrichment may be too mild to counter the 
dramatic psychoneuroimmunological changes that take place post SCI.   
Finally, a third explanation for our results is that we did not implement social 
enrichment with the most appropriate form of group housing.  Numerous group housing 
protocols exist.  Certain studies provide social enrichment by housing subjects in groups 
of four in a large pen-like cage (Azar et al., 2011), 6 rats (Berrocal et al., 2007) or even 
ten (Moncek et al., 2004).  Others combine social enrichment with physical enrichment, 
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providing animals with a variety of objects every day (Ravenelle et al., 2014). Animal 
density, duration of group housing prior to experimental procedures, and cage size, 
among others, are all factors that can influence behavior (Burke et al., 2007).  Because 
our experimental subjects were contused and thus technically vulnerable to physical 
attacks in the days following the surgery, we opted for a group housing paradigm which 
consisted of only two rats housed together.  It may be that in order to observe the 
beneficial effects of group housing, it would have been necessary, for example, to house 
a larger number of subjects together, in a larger cage, or begin group housing prior to 
SCI.  Nonetheless, our experiment allowed us to stumble on an interesting and 
unexpected finding regarding the effect of spinal cord injured subject exposure on intact 
cagemates. 
The caregiver effect  
Providing care for a spouse, parent, or child suffering from a long-term disease is 
a source of chronic stress.  The incidence of depressive symptoms in such caregivers is 
high- up to 50 % (Arango-Lasprilla et al., 2010; Rodakowski et al., 2013)- and 
frequently accompanied with high levels of inflammation (Fonareva & Oken, 2014), 
making caregivers prone to illness.  In Chapter V, we noticed that intact animals housed 
with a contused subject displayed levels of learned helplessness and passive anxiety 
comparable to those of contused subjects.  Although we did not observe differences in 
alpha-2 macrogloublin levels between the two groups, these intriguing results point to an 
effect of caregiving, possibly mirroring that reported in humans.   
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We can only hypothesize on the mechanism underlying the decrease in 
psychological well-being in intact animals housed with a contused cagemate.  One 
possibility, for example, involved kidney malfunction, which often accompanies SCI in 
both humans and rodent models (Pettersson-Hammerstad, Jonsson, Svennung, & 
Karlsson, 2008; Rodriguez-Romero, Cruz-Antonio, Franco-Bourland, Guizar-Sahagun, 
& Castaneda-Hernandez, 2013).  Glomerular function can decrease post SCI, and this is 
associated with the development of proteinuria (Vaidyanathan, Abraham, Singh, Soni, & 
Hughes, 2014).  Therefore, it is possible that traces of acute phase proteins and/or stress 
hormones are excreted in the urine of contused subjects.  Exposure to these proteins may 
result, for example, in activation of the HPA axis in intact cagemates.   
In the clinical setting, the caregiver effect is an important aspect of SCI, and yet, 
it has been so far overlooked by animal research.  An animal model of SCI caregiving, 
potentially based on our experimental design, may help better understand, at a biological 
level, the physiological and psychological effects of caring for an SCI family member.   
Conclusion 
In this dissertation, we tested the hypothesis that SCI-induced inflammation 
decreases psychological well-being and that, in turn, psychological well-being affects 
SCI recovery.  To test this hypothesis, we conducted three experiments.  Chapter III 
assessed the impact of SCI on psychological well-being at the behavioral level, and 
examined one biomarker of inflammation in relation to depression and anxiety-like signs 
post SCI.  Chapter IV further examined cytokine and chemokine levels post SCI as a 
  
187 
 
function of injury and psychological well-being both peripherally (serum) and centrally 
(brain and spinal cord).  Finally, Chapter V explored the inverse relationship; that is, that 
psychological well-being (modulated with group housing conditions) affects SCI 
recovery.  As illustrated in Figure 50, with the data obtained throughout these three 
studies, we were able to identify a relationship between (1) spinal cord injury and 
inflammation, (2) inflammation and psychological well-being (depression and anxiety), 
(3) inflammation and pain, and (4) pain and psychological well-being.  However, the last 
relationship studied, (5) psychological well-being and spinal cord injury recovery, could 
not be confirmed.  
The experiments in this dissertation are the first to both examine depression and 
anxiety following SCI, and obtain a tableau of changes in immune system activation post 
SCI in the spinal cord, the brain, and the serum.  Furthermore, we are the first to report a 
possible caregiver effect in an animal model of SCI.  These findings provide 
confirmatory evidence that inflammation post SCI is associated with depression and 
anxiety.  In the future, it will be necessary to conduct further molecular and 
pharmacological studies to determine the causal role of inflammation in psychological 
well-being post SCI.  It will also be interesting to investigate the mechanisms underlying 
the caregiver effect post SCI.  With this work, we have demonstrated that the depression 
and anxiety patients experience following spinal cord injury is not due solely to 
psychosocial factors, but may also, in part, result from increased immune activation 
following the injury.  This constitutes one important step forward in improving our 
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understanding of mental health following SCI, and providing more appropriate 
psychiatric support for spinal cord injured patients. 
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